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INTRODUCTION. 
Pneumonia has long held a place in the forefront 
of fatal diseases. . Despite the many investigations 
which have been carried out regarding its etiology 
and pathology, the therapeutic problem has remained 
one of pressing importance. The absence of any 
definite specific form of treatment has made pneumonia 
one of that long list of conditions in which the 
doctor could do little more than deal with the symp- 
toms as they arose. In such a state of affairs, 
then, there was more than a grain of truth in the wel{. 
known statement that the successful outcome of a case 
of pneumonia depended in no small measure on the 
nursing. 
The first advances against the stronghold of 
pneumonia followed upon the discovery of Docher and 
Gillespie', who were able to show that the pneumo- 
coccus could be classified into Types I, II, III and 
Group IV. This important information led to the pre- 
paration of pneumococcal antisera which were used in 
the treatment of the disease. A certain amount of 
benefit was found to result in infections due to 
Types I and II pneumococcus, but this was dependent 
2. 
upon the administration of the serum at a very early 
2 
stage. A further step -vas made when Cooper et al 
showed that the heterogeneous Group IV consisted of 
at least twenty -nine varieties of pneumococcus which 
they named Type IV to XXXII. Later Dowling and 
Abernethy" reported that antisera were effective 
against Types V, VII and VIII. Treatment by serum, 
however, had several important disadvantages. In 
the first place favourable results were dependent on 
its early administration. Secondly, it was neces- 
sary to know with what type of pneumococcus one was 
dealing, an insuperable difficulty in any but well 
equipped hospitals. Thirdly, serum could be adminis 
tered only in hospital in the majority of cases, and 
fourthly, a point of no little importance, the cost 
was considerable. It could not then be said that t 
problem of the treatment of pneumonia had been solve 
by the advent of serum and the quest for some univer- 
sally applicable therapeutic measure had to continue. 
Since the time of Erhlich's discovery of the 
effect of the mercurial drugs on spirochaetal infec- 
tions, advances of great importance have been made in 
the therapeutic control of the higher forms of micro- 
organisms. No substance, however, had been found 
3. 
which would act effectively in vivo on the lower grade 
bacteria. It was at this stage then that in 1935 
Domagk4 and his associates Meitzch and Klarer found 
that an azo -dye containing a sulphanamide group was 
effective in the treatment of streptococcal infec- 
tions. This preparation was known as Prontosil. 
Shortly after its discovery it was found that the 
active properties of the drug lay in the colourless 
part and the original prontosil became replaced by 
that portion known as Sulphanilamide. This treat- 
ment of streptococcal infections by Sulphanilamide, 
so simple in use and so universally applicable, open- 
ed up a field of tremendous possibilities and it was 
natural that, almost immediately, the effect of this 
drug in diseases caused by other organisms should be 
investigated. That an enquiry into its effective- 
ness on pneumococcal infections was carried out at 
an early date is in no way surprising. 
Originally Domagk gave the impression that 
Sulphanilamide had some action on Type III pneumoccccus, 
but none on Types I and II. Later, Nitti Bovet and 
Depierre5 found that, in vitro, sulphanilamide had an 
inhibitory effect on the pneumococcus, mile Britton6 
noted a definite but variable bactericstatic and 
4. 
bactericidal effect on Types I and II and on Group IV 
pneumococcus. Whitby, however, found almost no pro- 
tection given by sulphanilamide against 10,000 lethal 
doses of Type I pneumococcus. On the whole, then, 
the effect of sulphanilamide on the pneumococcus was 
variable and the final impression was that results 
did not seem to justify its use in the treatment of 
Pneumonia. 
Fortunately, however, this failure of Domagk's 
sulphanilamide in its action against the pneumococcus 
did not end the story. His discovery had given a 
new stimulus to the treatment of disease by chemo- 
therapeutic measures and almost immediately a large 
number of compounds allied to sulphanilamide were 
prepared by the research chemists. Several of these 
substances were found to be more active than sulph- 
anilamide against the pneumococcus but had the dis- 
advantage of being relatively toxic. Thus Buttle7 
found that the benzylidene Schiff's base of diamino- 
diphenylsulphone was more effective than sulphanila- 
mide in prolonging the life of mice infected with 
Type I pneumococcus and that half the mice infected 
with one lethal dose survived for thirty days. This 
prepafation, however, was four times as toxic as 
5. 
sulphanilamide. Similarly, Whitby8 found the diamino 
benzene sulphanilamide compounds about three times 
more efficient than sulphanilamide for Type I infec- 
tions in mice. After comparative examinations of 
large number of compounds, the preparation 2- sulphani 
lyl- aminopyridine was selected for further investiga- 
tion. This product was first prepared in the 
chemical laboratories of May and Baker, Ltd., in 
England, and has been given the popular name of 
Y. & B. 693. 
The experimental trials of M. & B. 693 were 
carried out by Whitby9, using mice infected with the 
pneumococcus. He found that the drug gave protectio 
against pneumococci of Types I, II, III, V, VII and 
VIII. He also concluded that for the experimental 
animal the drug had a low toxicity. Support for 
Whitby's finding was forthcoming from the results of 
in vitro experiments carried out by Fleming10. 
Following upon the experimental evidence of Whit y 
and Fleming, the next step was to administer M. & B. 
693 to man and to observe its effect on human pneumo- 
coccal infection. In July 1938 Evans and Gaisfordll 
published. a report on two hundred cases of lobar 
pneumonia, half of which were treated with M. & B. 69 s . 
6. 
In those treated with the drug the mortality was 8 
per cent., while in the control series it was 27 per 
cent. 
The possibility then, that a preparation had 
been discovered which would give effective results i. 
the treatment of pneumococcal infections in man was 
something of no little interest to all concerned in 
medicine. At this stage M. & B. 693 was becoming 
available for trial and I therefore determined, if it 
were at all possible, to observe its effects for 
myself. 
After qualifying in 1936 and having spent eight- 
een months in hospital and six months in general 
practice, in October 1938 I became resident house 
physician to Dr W. A. Alexander in the Royal Infirma 
Edinburgh. Through his kindness and that of other 
members of the honorary staff, I was enabled to visit 
all the cases of pneumonia admitted under six of the 
medical charges and to follow their treatment with 
M. & B. 693. 
In carrying out any investigations as a house 
physician, there are of necessity certain limitations 
in view of the pressure of routine duties and the wore 
of running medical wards. Under the circifm.tances, 
7. 
then, it seemed that the observations which could be 
made with the greatest care and success would un- 
doubtedly be those of a clinical nature. Having 
thus pondered and realised my limitations as regards 
any investigation I might make into the treatment of 
pneumonia with M. k B. 693, the question then arose 
as to what light, if any, might be thrown on the 
matter by such an enquiry. 
At first the consideration of this question 
filled me with despair, for as a resident in hospita 
one is surrounded by well equipped clinical labora- 
tories. In consequence one is apt to feel that no 
investigation is complete which does not employ some 
of the many tests that may be carried out there. I 
knew that I had neither the time at my disposal nor 
the necessary aptitude to carry out these clinical 
laboratory investigations of the effect of M. & B. 6 
on pneumonia. Some consideration, however, led me t 
conclude that an investigation from a mainly clinical 
standpoint might give information of no small useful- 
ness, and indeed the more I thought of it the greate 
seemed its importance. 
The reports of the first trial of the drug M. & 
B. 693 (Evans & Gaisfordll) in human beings suffering 
8. 
from pneumonia had shown that in the majority of case - 
certain dramatic results had been obtained - results 
which, if they were substantiated by further observa- 
tions, indicated that the course and ultimate outcome 
of pneumonia were going to be greatly changed. If 
then I could treat a reasonable number of cases with 
M. & B. 693 and observe from the clinical standpoint 
the result of such treatment, an opinion could be 
formed as to its efficiency or otherwise. In the 
event of such observations justifying the conclusion 
that the drug influenced the course of pneumonia 
favourably, certain other important questions must th 
be answered. 
It is well known that a drug which can be used 
in hospital where every facility is available for its 
administration and control cannot always be employed 
with ease in other surroundings, particularly those 
met with in general practice. M. & B. 693, then, 
might prove itself of great service in the treatment 
of pneumonia, but its use with safety might entail 
elaborate investigations, for example regarding its 
concentration in the blood stream, its rate of ex -. 
cretion by the various routes, and so on. Should 
such prove to be the case, then the scope of the drug 
en 
9. 
would be greatly reduced from the outset. If on the 
other hand it was found that an adequate concentration 
could be attained and maintained in the blood after a 
stated dosage, that such dosage produced the expected 
result and gave the necessary margin of safety, then 
useful information had been gained regarding this 
drug M. & B. 693. 
The next step, having been satisfied as to its 
effectiveness, safety and reasonable facility of use, 
was to enquire into the question of how extensively it 
might be employed against the pneumococcus. The 
pneumococcus which is most often the causal organism 
of pneumonia has now been differentiated into thirty 
two types, each showing agglutination to specific 
sera (Dochez and Gillespie1at Rockefeller Institute, 
New York, and Cooper, Rosenstein, Walter and Peizer2). 
It was now necessary to reach a conclusion as to 
whether or not 1T. & B. 693 had a useful effect in 
pneumonia, as it affects human beings, due to any one 
of these thirty two types of pneumococcus occurring 
singly or as a mixed infection. Was it more effective 
against one type of pneumococcus than another, or the 
same in its action against all? The efficacity of 
the drug in pneumonia due to organisms other than the 
lo. 
pneunococcus, e.g. the streptococcus, was also of the 
utmost importance. In fact it would be necessary to 
form an opinion as to whether, should a case be diag- 
nosed clinically as pneumonia, the administration of 
M. & B. 693 could be depended upon to give uniform 
results in the majority of cases. This latter ques- 
tion is one of outstanding importance on consideratio 
of the fact that facilities for determining the type 
of the infecting organism are not always available. 
An answer having been given to the foregoing 
questions - should L. & B. 693 have been shown to be 
satisfactory in these respects - it still remained to 
be seen whether or not this drug presented any advan- 
tages over other forms of treatment already in use. 
To reach a conclusion on this point in a clinical in- 
vestigation it would be necessary to consider certain 
factors. The first of those factors would be the 
effect of the drug on the mortality from pneumonia. 
It has long been known that the severity of pneumo- 
coccal infections varied from year to year (Painton 
and Ulrich12) and consequently the mortality has also 
been variable. At the same time the death rate has 
never been in any sense a low one. Thus cases ad- 
mitted to the Royal Infirmary, Edinburgh, show the 
11. 
following mortality figures for all cases of pneu- 
monia.- 
1933 -34 .. .. 23.28% 
1934 -35 .. .. 28.4% 
1935 -36 .. .. 41.66% 
1936 -37 .. .. 40.2% 
1937 -38 .. .. 30.22 %. 
The mortality also varies in the different Types 
of infection. In Type I infection, then, the Medica' 
Research Council's13 mortality figure was 15 per cent. 
and that of Cruikshank14 from a series of cases in 
Glasgow 10.8 per cent. Cecil15 in America, from a 
large number of cases, reported a mortality of 28.8 
per cent. In Type II infections these three 
authorities publish mortality figures which are 
slightly higher than for Type I, viz., Medical Re- 
search Council 27 per cent., Cruikshank 21 per cent. 
and Cecil 48.8 per cent. With regard to Type III 
there is general agreement that this organism is prone 
to attack people over 40 years of age and in them is 
peculiarly fatal. It has generally been thought 
that the mortality from Group IV infections was lower 
than from other forms. Thus Cruikshank reported 8.6 
per cent. and Davies, Hodgson and Whitbyló 7 per cent. 
These figures are in striking contrast to that of 31 
per cent. quoted by Cecil. 
12. 
If, then, a significant alteration in these 
figures could be shown to occur in cases treated wit. 
M. & B. 693, information of the greatest importance 
regarding the drug would have been obtained. 
Further, by clinical observation the effect of 
the drug on the course of pneumonia could be observe. 
Regarding the effect of M. & B. 693 on the course of 
the disease, three important questions presented 
themselves for answer. Firstly, what effect did the 
drug have on the course of the severe stage of the 
illness - that period during which the patient has a 
high temperature, greatly increased respiratory rate, 
is very toxic and often gravely ill? Could it be 
shown that M. & B. 693 in any way influenced this 
most anxious period of the disease - was this period 
in any way shortened or made less severe? Secondly, 
was the period of convalescence influenced in any wa'? 
Was the patient able to get out of bed sooner? 
Thirdly, was he able to return to his work at an ear- 
lier date than after other forms of treatment? 
In this connection the question of the time taken 
for the inflammatory process in the lungs to resolve 
was of importance. In a typical case of lobar pneu- 
monia all signs in the lung have usually disappeared 
13. 
fourteen days after the onset of the disease (Price, 
F. W.17). Was then this period of resolution short- 
ened or was the action of M. & B. 693 such that some 
delay occurred in this stage of the illness? 
Perhaps the most common serious complication of 
pneumonia is the occurrence of empyema and consequent 
ly one point of great interest in this clinical study 
of pneumonia treated with M. & B. 693 would be its 
effect on the occurrence of empyema. That then was 
the incidence of empyema in cases of pneumonia treate 
with M. & B. 693? Could it be said that fewer or 
more cases occurred with this form of treatment than 
before its inception? 
One of the most important factors which deter- 
mines the suitability for use in human beings of any 
drug is the presence, and should it exist, the degree 
of its toxicity. Vital information concerning this 
very important point is certainly obtained by obser- 
vation of effects of administration of the drug to 
animals. The final test, however, taking guidance 
from the results of animal experiments, must be the 
giving of the drug to a human subject, the while care 
fully watching all the ways in which toxicity may 
show itself. Thus in my clinical study it would be 
14. 
necessary to be continually watchful for signs of 
severe toxic symptoms - signs which might indicate 
that the effects of the drug were of themselves as 
dangerous as the disease. The occurrence of symptoms 
of this nature would immediately indicate the unsuita- 
bility of the drug for use in disease in the human 
subject. At the same time it would be necessary to 
distinguish from these toxic symptoms those phenomena 
which, while they might be regarded as due to the use 
of the drug, would be of insignificant import and 
constitute only an inconvenience and not a danger or 
contraindication to its use. In the event of the ap- 
pearance of these relatively harmless manifestations, 
could anything be done to overcome or circumvent them? 
Having treated a number of cases with M. & B. 69 
it should be possible to form some opinion as to the 
cost of the amount of the drug necessary to bring 
about the desired effect. Could it be said that this 
form of treatment was within the reach of everyone's 
pocket? 
From a clinical investigation it should, then, be 
possible to reach conclusions on these various points 
These conclusions having been drawn, it should then b 
possible to answer a final question. Could the drug 
15. 
M. & B. 693 be used with safety and reasonable cer- 
tainty of good results by the general practitioner of 
medicine? For only when a drug can be used by all 
members of the profession, no matter the conditions 
under which they work, can it be said to be in the 
highest degree useful. 
16. 
THE ACTION OF M. & B. 693. 
The drug now known in this country as i,". B. 693 
is related to both Sulphanilic acid and Amino -pyridine 




In earlier publications it was referred to as 
2- p- aminobenzenene- sulphanilamide pyridine, but is 
now referred to as 2- sulphanilyl- aminopyridine. 
Because the drug is universally known as ,. & B. 693 
and for simplicity I shall refer to it by this name 
throughout. 
Properties of Y. . B. 693. 
Y. & B. 693 is a white or nearly white crystal- 
line powder melting at 190 -193 °C. and having a slight- 
ly bitter taste. It is soluble in water to the ex- 
tent of about 1 in 1000 and it is sparingly soluble in 
the usual organic solvents. M. & B. 693 possesses 
acid and basic properties. It is the free amino 
group which confers the basic properties while the 
acidic properties depend on the sulphonamide hydrogen. 
17. 
Fate of M. B. 693 in the Body. 
Despite its sparing solubility in water (1 in 10 0) 
M. & B. 693 has been shown to be rapidly absorbed fro 
the gastro -intestinal tract in animals (mice, rabbits 
and dogs), and in the human subject. (Baines and 
Wien18.) These investigators have found measureable 
quantities of the drug in the blood stream within one 
hour of ingestion. As with sulphanilamide, Y. & B. 
693 is detoxicated by acetylation in both rabbits and 
human beings (Stokinger19). Feinstone and Long20 
find that the acetylated form of the drug has little 
or no chemo- therapeutic effect. In rabbits, Baines 
and Wien18 found that the administration of a dose of 
0.5 mgm. per gm. M. & B. 693 a concentration of 1 in 
10,000 was reached and in mice doses above 5 mgm. 
resulted in a blood level of 1 in 3,000. In rabbits 
they found that after giving 0.5 mgm. per gm. of the 
drug by stomach tube, the concentration of & B. 693 
in the blood stream reached its maximum at the end of 
the second hour with the value of 11 mgm. per 100 c. 
cm. After five hours the concentration had dropped 
to half this level and at the end of twenty -four hours 
the drug was completely absent from the blood stream. 
The free amino body was present in a concentration of 
75 per cent., while the conjugated form reached the 
18. 
level of 25 per cent. Further determinations shows 
that all the free amino body was present in the se 
This latter observation is in accordance with the 
findings of Fleming10, who found the activity against 
pneumococci rested in the serum of patients treated 
with the drug. 
In man, Baines and Wien18 found that single dose 
of 1 gm. and 2 gm. gave concentrations in the blood o 
1 in 50,000 and 1 in 25,000. Further, they observed 
that following a single dose of 1 gm. P. & B. 693 the 
drug appeared in the blood after one hour, reached its 
maximum in from five to seven hours, falling thereafter 
and being completely excreted in fifty hours. 
In experimental administration of the drug to a 
patient, Hobson and McQuäde21 found that 1 gm. given at 
two hourly intervals produced a concentration in the 
blood of 1 in 10,000. 
Long and Feinstone ?s20 results showed that a dose 
of 0.05 gm. per gm. to a man produced a maximum blood 
concentration of 3.2 to 5.6 mgm. per 100 c. cm. in 
four hours and that almost all the drug was present 
as the free amino body. 
That M. & B. 693 can penetrate to other tissue 
fluids is shown by the observations of Hobson and 
McQueide21 who found the drug in the cerebro- spinal 
19. 
fluid in concentrations of approximately fifty per 
cent of that in the blood. Its presence has also 
been demonstrated in purulent pleural exudates by 
Long and Feinstone22, who found there a concentration 
of half to two thirds that in the blood. 
Variations in the concentration of the drug in 
the blood stream were shown to occur by Hobson and 
McQusde21. In a patient suffering from meningococcal 
meningitis treated by them with M. & B. 693, the 
maximum concentration reached in the blood streg ~n was 
4 to 6 mgm. per 100 c. cm., while in a trial adminis- 
tration after the patient's recovery the maximum con- 
centration was between 8 and 10 mgm. per 100 c.cm. 
They concluded from their work that the concentration 
of M. & B. 693 in the blood stream might vary with the 
state of the patient's health, the state of alimentary 
tract and probably with the fluid intake of the 
patient. Stokinger19 found that where there was a 
high level of acetylation the concentration of the 
free form in the blood was low, and states that the 
wide variation of the drug in different cases might 
depend on three possible factors, viz. rate of absorp- 
tion, rate of acetylation and rate of elimination of 
free and acetylated forms. In general he found that 
cases on a higher dosage tended to have a higher blood 
20. 
concentration. This latter observation is borne out 
by Graham et al. 
.Excretion of M. & B. 693. 
The experiments of Baines and Wein18 lead them 
to believe that the drug is excreted almost entirely 
in the urine, there being only a very small percentage 
present in the faeces. They found the drug in the 
urine about one hour after ingestion, one half as the 
free amino body and the remainder as the acetyl com- 
pound. Excretion was found to be complete fifty 
hours after the administration of 1 gm. to a man. 
Long and Feinstone20, giving 0.05 gm. to a man at six 
hourly intervals for one day, found that 65 per cent. 
of the drug was excreted in three days and that amounts 
varying between 30 and 70 per cent. were present as the 
free amino body. Stokinger18 recovered 1.82 and 2.4 gm. 
of the acetyl derivative of 1. & B. 693 in two twenty 
four hour specimens of urine from a patient who had 
received 9.5 gm. of the drug over a three day period; 
no free drug in the urine after 24 hours; acetylated 
form absent 48 hours. He also found crystals of the 
acetyl compound depositing spontaneously in the urine 
of rabbits and men. 
21. 
Mode of Action of M. & B. 693. 
Whitby9 was among the first to publish evidence of 
the activity of this drug using the pneumococcus as 
the test organism. He found that six doses of 30 to 
40 mgm. of 1v_. B. 693 gave complete protection to 
mice inoculated with 10,000 lethal doses of Type I 
pneumococcus and that in doses of 20 to 40 mgm. there 
was complete protection against Types VII and VIII. 
In Types II, III and V, protection was not complete 
but was high. In the experiments on Type I pneumo- 
coccal infection observations were carried out on 
forty -two mice for a period of fourteen days after thi3 
conclusion of treatment and no late deaths occurred. 
Thirty mice were reinoculated at the end of the first, 
week with another 10,000 lethal doses and were found 
to be immune to this second infection. 1 
Following upon the publication of the above find- 
ings, investigations were carried out in an endeavour 
to elucidate the mode of action of the drug on the 
Pneumococcus. 
Fleming'sl '~3 in vitro experiments led him to 
conclude that I. B. 693 had a powerful bacteriostatic 
effect in deleucocyted blood and that when it was pre- 
sent in normal blood in 'suitable' concentrations 
there was increased destruction of pneumococci. 
22. 
Leucocytes were necessary for this destruction. In 
a later communication he states that the anti -bacteri 1 
power lies in the serum, and that the efficiency of 
the leucocytesis not increased. He further conclude 
that M. & B. 693 added to human blood or contained in 
the blood of patients taking the drug does not prevent 
encapsulation of pneumococci. 
McIntosh and Whitby24 carried out experiments 
dealing with the effect of the drug on the specific 
and non -specific body defences and with its action on 
the bacteria. Their findings support the view that 
M. & B. 693 has no stimulating effect on the leuco- 
cytes, phagocytic cells or the specific immune de- 
fences of the body. They go further and say that 
since an in vitro effect can be demonstrated in serum 
or broth as well as in whole blood, it would not seem 
that leucocytes are a primary requirement. 
Several interestinr; features were brought to 
notice regarding the action of the drug on the bacteria. 
It was demonstrated that in the presence of M. B. 693 
the bacteria multiplied for about four hours and it 
was not till after this interval that any counter 
effect was seen. Further, the drug was observed to 
be inactive against rough or avirulent cultures. The 
explanation advanced by the authors to explain these 
23. 
findings is that M. & B. 693 in some way interferes 
with the essential food supply of the organisms. The 
fact that the drug is inactive against rough and 
avirulent organisms, they say, tends to support this 
view in that the food demand of these organisms is not 
so exacting. 
A further effect observed in their experiments 
was the phenomenon of capsular degeneration, found in 
vivo and only in peritoneal samples. This capsular 
degeneration has also been observed by Telling and 
Oliver25 in the sputum of a patient suffering from a 
Type III pneumococcal infection. Using Gram's stain 
they examined a specimen of the patient's sputum 
after the administration of 3 gms. M. & B. 693. The 
organisms were found to be scanty, pleomorphic and 
non -capsulated. Primary culture yielded a pure 
atypical growth, not agglutinated by Type III or any 
other serum. Mouse inoculation yielded an exudate 
which on culture showed the same pure atypical growth 
and no agglutination by any serum. Passage of this 
strain restored its previous characteristics. 
In experimental work. Hilles and Schmidt26 found 
decapsulation of pneumococci from peritoneal fluid 
after death. They proved that these decapsulated 
organisms were avirulent. 
24. 
Experimental evidence regarding, the concentration 
of the drug necessary to be effective against the 
pneumococcus has been furnished by McIntosh and 
Whitby24. Using 2 c.cm. citrated rabbit's blood they 
found that the limit of activity of M. B. 693 in a 
concentration of 16 mgm. per 100 c. cm. was somewhere 
between 50,000 and 150,000 pneumococci: 8 mgm. per 
100 c.cm. was effective against 150, 4 mgm. against 2, 
and that concentrations of 2 mgm. per 100 c.cm. were 
ineffective against the smallest inoculum. 
In the human subject, Flippin et al27 examined 
the blood level in two series of cases treated with 
& B. 693. The end results in eleven patients 
showing a blood concentration of 1 to 2.8 mgm. per 
100 c. cm. were compared with those of eleven patients 
showing a blood concentration of 10 to 18 mgm. per 
100 c. cm. Nine of the patients in the former group 
showed a fall in the temperature in the first twenty - 
four hours, while only six in the latter showed a 
fall of temperature in the first twenty -four hours. 
From these findings they concluded that a concentra- 
tion of 10 mgm. per 100 c.cm. or more, was unnecessary 
and produced no greater effect than a concentration 
of 1 to 2.8 mgm. per 100 c.cm. 
Graham et a128 found that a concentration of 
25. 
10 mgm. per 100 c.cm. was the exception rather than 
the rule even with dosages as high as 12 gm. in the 
first day of treatment and 9 gm. on the second. With 
this dosage they found concentrations varying from 
2.3 mgm. per 100 c.cm. to 17 mgm. per 100 c.cm., the 
majority being in the region of 7 to 8 mgm. per 100 
c.cm. which was effective. 
In this series of cases I have not carried out 
any estimations of the concentration of the drug in 
the blood stream as the endeavour has been to keep the 
survey completely along clinical lines. It has been 
found that a dosage varying in the average from 6.5 
gms. to 8.5 gms. given in the first thirty -six hours 
is sufficient to give an adequate concentration in the 
blood as judged by the effect on the temperature, 
pulse and respirations and general condition of the 
patient. If a dosage of this size was spread out 
over a longer period in its administration, the time 
taken for general improvement in the patient's condi- 
tion was correspondingly longer. This fact may be 
exemplified in case K2, in which a dosage of 7 gms. 
was given over a period of seventy -two hours with a 
fall of temperature, etc., after this time. Simi- 
larly in case L4, where 7 gms. was given in a period 
of thirty -two hours. It therefore seems probable 
26. 
that in the majority of cases which are going to re- 
spond to Y. & B. 693 a dosage of 6.5 to 8.5 gms. 
should be given within a reasonably short period of 
time, possibly within the first twenty -four hours. 
Toxic Effects of N. & B. 693. 
The toxicity of Y. & B. 693 for animals was in- 
0 
vestigated by Wien2`'. The daily administration of 
0.5 mgm. per gm. to rats for two weeks had no effect 
on the blood or urine, and similarly, doses of 1 gm. 
daily for seven days to dogs and cats had no effect 
on the blood, urine or general health. Y. & B. 693 
given in two and four times the dose of sulphanilamide 
caused no increase in excretion of urinary porphyrin 
or decrease in the red cell count. Toxic symptoms, 
however, have been recorded in man, the most common 
being nausea, vomiting, headache and malaise (Flippin 
et al27, Lloyd et al30, Cunningham31, Batchelor3and 
Brown33). In the majority of cases these symptoms 
were not sufficiently severe to interfere with treat- 
ment. Batchelor et al32 found that a reduction in 
dosage overcame the symptoms. But Graham et al28 
have stated that in the presence of nausea and vomiting 
continuance of the drug tends to decrease rather than 
increase the symptoms. Barnett et al34 are in 
27. 
agreement with this. 
Among methods employed to overcome the above 
toxic symptoms, Flippin et al27 have found the fol- 
lowing methods of use, viz. the administration of 
small amounts of soda bicarbonate, crushing the tablets 
and administering in milk, passing a duodenal tube anal 
administration of the drug through this. These 
means have also been found effective by Fahrni35. 
Skin rashes have been 
tion of cases. Batchelor 
present in a small propor - 
et al32 observed dermatiti 
in six out of one hundred and two cases of gonorrhoea 
treated with the drug, Graham et al28 in two out of 
fifty cases of pneumonia, and Fahrni35 in one out of 
twelve cases of pneumonia. In all cases the rash 
disappeared within a short time of discontinuance of 
the drug. 
Hallam36 has reported a case in which the rash 
appeared only after exposure to ultra -violet light. 
The occurrence of haematuria has been observed 
four out of fifty patients by Graham et al28, who f 
jagged crystals of the drug in the urine of these 
patients. 
Though very few cases have been reported, the 
most serious complication has been agranulocytosis. 
Graham et al28 found a white cell count of 900 per 
28. 
c.mm. in a patient who had had 79 gm. of the drug, but 
who recovered with stoppage of the drug. Barnett et 
al34 recorded a case in which the white blood cells 
fell to 75 per c.mm. after 80.9 gm. of the drug. Th 
count subsequently rose to 22.500 per c.mm., but the 
patient died later of haemorrhage from cervical aden- 
itis. On the whole, therefore, it would seem that 
the toxic effects of M. & B. 693 are mild, are quickly 
recovered from and produce no lasting effect. 
In this series of 82 cases the toxic symptoms 
have been of little consequence. The only ones ob- 
served been cyanosis and vomiting, both of which 
have been transient and had no lasting effect. In 
the majority of cases the treatment has been continue 
in spite of these symptoms, the tablets being given 
crushed in milk or with sodium :bicarbonste. The white blood 
count has been observed throughout the cases and no 
significant fall has been recorded during the adminis- 
tration of the drug or following its cessation. 
29. 
ETIOLOGY AND PATHOLOGY OF PNEUMONIA. 
Pneumonia is an acute inflammation of the lungs 
due to bacterial invasion, the disease being character- 
ised by fever, toxaemia of varying degree and by evi- 
dence of pulmonary consolidation. The disease is 
one of the commonest phenomena in medical practice 
and has been sub -divided into several groups. 
Thus Burrell37 classifies pneumonia under the 
headings of - 
(a) Typical acute pneumonia. 
(b) Broncho- pneumonia following a foreign body 
in a bronchus. 
(c) Secondary pneumonia - probably a plug of 
mucus causing collapse. 
(d) Sub -acute and Chronic pneumonia. 
ETIOLOGY OF PNEUMONIA. 
More recently the importance of the organisms 
causing the disease has come to the front. Any 
organism entering the respiratory tract may cause 
pneumonia, but certain bacteria are more commonly re- 
sponsible. Thus although the main organism is un- 
doubtedly the pneumococcus, the importance of the 
Streptococcus, B. Friedlander and the causal organisms 
of Influenzal Pneumonia cannot be dismissed lightly, 
30. 
as Gaskell has shown that the outcome as far as the 
lungs are concerned depends on the type of organism. 
Streptococcal pneumonia does not commonly affect 
healthy adults and appears more often at the extremes 
of life - in the young and in the aged. When it 
attacks an adult it is usually when he is in a condi- 
tion of lowered resistance. The non -haemolytic 
streptococcus is an organism of low virulence and 
pneumonia due to it occurs usually as a terminal event, 
but it may be responsible for a mild form of pneumonia 
with a low mortality. 
The haemolytic streptococcus, on the other hand, 
produces a widespread pneumonia which is liable to 
be complicated by abscess formation and empyaema. It 
is also prevalent as a secondary invader in influenzal 
pandemics. 
The E. Friedlander is fortunately not a common 
causal agent in pneumonia.as it is peculiarly fatal. 
The staphylococcus usually occurs as a secondary 
invader and is more likely to cause the so- called 
broncho -pneumonia with abscess formation. 
The modern conception of influenzal pneumonia is 
that it is due to a virus. It would appear that this 
virus is capable of lowering the resistance to such a 
degree that the lungs lie open to attack by a second 
31. 
invader. The secondary invader may be the pneumo- 
coccus, streptococcus or staphylococcus, but in many 
cases is the B. Pfeiffer, which is found in large 
numbers in many cases of this type. 
PNEUM0C0CCAL PNEUMONIA. 
Bacteriology and Etiology. 
The typical appearance of the pneumococcus is 
that of a lanceolate or oval coccus in pairs, with 
the rounded ends together. It is about 1 9. in its 
long diameter and shows a thick capsule which appears 
as an unstained zone round the organism unless posi- 
tively stained by special methods (Mackie & McCartney 38 ). 
In 1913 Dochez and Gillespie1, investigating a series 
of cases of pneumonia in search of a specific therapy 
showed that the pneumococcus could be divided into 
four definite groups, which they designated, Type I, 
Type II, Type III, and Group IV. Types I, II and II] 
were shown to be sharply defined from each other and 1 
from Group IV by their agglutination with specific 
type antisera. 
No further differentiation of the pneumococcus 
was attempted till 1929, when Cooper et a12 started 
to investigate the homogeneous Group IV. Ultimately 
32. 
these workers were able to show that this group con - 
tained at least twenty -nine antigenic types, sharply 
defined from each other and differentiated by specific 
agglutination. The possibility that other types of 
pneumococci do exist is not ruled out, but it seems 
probable that the types pathogenic to man are all con- 
tained in Types I, II, III and the twenty -nine varie- 
ties of Group IV, named from Type IV to Type XXXII, 
(Topley and Wilson39). 
The capsule of the pneumococcus has been shown 
to be responsible for the antigenic behaviour of the 
organism. According to Topley and Wilson39, the 
antigenic structure of the pneumococcus may be as fol- 
lows: there is a central protoplasmic portion which 
in its antigenic behaviour is neither species nor 
type specific. At the cell surface is another com- 
ponent,mainly carbohydrate in nature and containing 
nitrogen and phosphorus, which is specific for the 
pneumococcus as a species. Finally, external to 
those in the normal smooth form is a capsule consisting 
wholly or in part of a polysaccharide which is specific 
for each pneumococcal type. There is reason to be- 
]ieve now, that besides being responsible for the anti- 
genic relationship of the organism, the capsule plays 
an important part in determining the virulence of the 
33. 
pneumococcus. 
That the pneumococcus may be present in the 
throat and nasal passages of normal individuals has 
been shown by Webster and Hughes40. They found the 
organism present in eighty per cent. of the normal 
people investigated by them and in ninety -seven per 
cent. it was serologically specific. Types I and II 
were found in one and two people respectively and 
under circumstances suggesting that these organisms 
were not able to spread rapidly. Types III and XII 
were present in nine people each and there was evi- 
dence to suggest spread from person to person. Type. 
XVI and XVIII were present in three people. Smillie4 
(1933) showed that Types III to XIX were prevalent in 
the throats of the general public and that the most 
frequent types were III, VI and XVIII. Sutliff and 
Finland42 found that eighty -four per cent. of their 
series was composed of Types I, II, VIII. V and VII 
in that order of frequency. Their investigations 
have led them to the further conclusion that in ninety - 
six per cent. of those shown to have Type V pneumo- 
coccus in the throat or nasal passages, pneumonia 
occurred, similarly in ninety per cent. of those with 
Type VSliand eighty per cent. of those showing Type 
VII. Generally speaking, then, while Types I and II 
34. 
are rarely found in the throat or nasal passages of 
normal people, other types occur with varying fre- 
quency. Usually it has been held that the organisms 
in the so- called Group IV are less virulent and that 
pneumonia is less likely to result from these organ- 
isms. Doubt as to the accuracy of this belief has 
been evidenced in the experiments of Sutliff and 
Finland42. 
PATHOLOGY and SPREAD. 
In its pathological description pneumonia has 
been divided into four stages, viz.- stage of engorge- 
ment, stage of red hepatization, stage of grey hepati- 
zation and resolution. In the stage of engorgement 
the blood vessels of the alveoli are swollen and en- 
gorged and there is an outpouring of fluid containing 
leucocytes and red blood cells into the alveoli. In 
the stage of red hepatization the lung is consolidate 
firm and airless. The overlying pleura has lost its 
shiny surface and is covered by a thin coat of fibrin. 
The alveoli are packed with firm clot composed of a 
meshwork of fibrin in which are entangled pneumococci, 
red blood cells and polymorphonuclear-leucocytes. 
When the process proceeds to grey hepatization, the 
lung becomes dense hard and heavy and its surface is 
35. 
covered with a thick layer of fibrin. The alveoli 
are packed with degenerated cells in the shape of 
leucocytes, a few red blood cells and numerous des - 
quamated cells. When resolution commences, the lung 
is soft, friable and very translucent, while the con- 
tents of the alveoli are more degenerated and less in 
quantity (cIcCallum46). 
In the production of pneumonia the experimental 
work of Blake and Cecil43 has been of great importance. 
Using monkeys they were able to produce lobar pneu- 
monia as it occurred in man. They found that inocul 
tions into the throat and nose or into the blood 
stream did not produce lobar pneumonia. To do so 
they showed it was necessary to inoculate the trachea 
and that this was the only means of producing the 
disease. This work, coupled with the knowledge that 
pneumococci may exist in the throat of healthy people 
makes it seem probable that the most usual, if not th 
only route of infection in man is by way of the trachea 
and large bronchi. 
After infection, Blake and Cecil showed that the 
initial invasion occurred close to the hilum of the 
lung. From there their evidence indicates that the 
infection invaded the lymphatics, peribronchial, peri- 
vascular and septal tissue and that the invasion of 
36. 
the alveoli took place from those interstitial tissue 
They further concluded that hepatization was central 
in origin, spreading thence to the periphery. More 
recent work has cast doubt on the possibility of this 
mode of spread and it seems probable that the opinion 
advanced by others - among them Terrell Robertson and 
Cogges°hall44 and Gunn and Nungester45 - is more 
correct. The view advanced by these observers is 
that the spread of infection takes place from alveolus 
to alveolus through Cohn's pores by means of infected 
oedema fluid. 
By means of X -ray, Davies Hodgson and Whitby16 
investigated the spread of the pneumonic process from 
its earliest stages in a series of patients under 
their care. They found that changes were first ap- 
parent in the hilar region in the form of an increase 
in the size of the hilar shadow and deepening of its 
density. From the hilum the opacity spread rapidly 
to the periphery which, in the majority of cases, was 
the last region involved. They noted that in the 
case of infections due to organisms of Type III and 
Group IV the process occasionally started at the 
periphery and spread inwards. In all cases spread 
took place rapidly and was well marked in the X -ray 
plate within twenty -four hours. 
37. 
DETERMINATION of PNEUMONIA. 
The question of what actually determines the on- 
set of an attack of pneumonia is still open to argu- 
ment. It seems likely that the virulence of the 
attacking organism and the resistance of the host must 
in some way be intimately concerned. The significance 
too, of the fact shown by Blake and Ceci143 that to 
produce pneumonia the organisms must reach the trachea 
and the observations of Webster and Hughes40, and 
Sutliff and Finland42, that the organisms except in 
the case of Types I and II may be present in healthy 
individuals, must bear some relationship one to the 
other. 
Stillman47 found that he could produce pneumonia 
in mice only when they had recovered from the effects 
of a previously inhaled spray of pneumococci. In 
man, Ward found that the blood of early untreated 
cases of pneumonia had a high capacity for killing 
pneumococci in vitro. Sutliff and Finland42 have 
shown that the blood of normal individuals had the 
power to kill pneumococci. They further observed 
that during the first two years of life this power 
was very small but that it increased with age, reaching 
its maximum about the age of forty. The pneumococci4 
tidal power of the blood of a normal individual appears 
38. 
to bear some relationship to the incidence of pneu- 
monia in various age groups. 
The abruptness of onset and rapid spread of the 
inflammatory process in the lung has suggested that 
the condition might be an expression of altered sensi- 
tiveness of the lung to the pneumococcus. Sharp and 
Blake48 in experimental work on rabbits reached the 
conclusion that the inflammatory process in the lung 
depended on an allergic state rather than on the in- 
herent injurious substances in their autolysate. 
rried49, investigating the allergic theory, injected 
small amounts of horse serum into the lungs of normal 
rabbits and showed this to produce a transient inflam- 
mation confined to the dorsal aspect. A further in 
jection of horse serum into the sensitised lungs pro- 
duced lobar pneumonia in a high percentage of cases. 
In man it has been shown by various observers 
(Clough50; Steinfeld51 and Kolmer; Bigelow52) that 
percentages varying between fifty and eighty -five of 
normal people react locally to an intracutaneous in- 
jection of pneumococcus antigen and that during the 
acute stage of pneumonia the skin is not reactive to 
these antigens. 
39. 
SELECTION and TREATMENT of CASES. 
A diagnosis of Lobar Pneumonia was established in 
all the cases of this series on clinical grounds. In 
many instances confirmation was given by X -ray examina- 
tion and, where any doubt existed, such an examination 
was always carried out. In view of the reports of 
Wein29 of the low toxicity of the drug, and the support 
given to this by the findings of Evans and Gaisfordll 
in their original series of cases, and because of the 
favourable results obtained by them, it was decided td 
make no selection of the cases admitted. All of their 
were treated with 2 sulphanilyl aminopyridine (Y. & B. 
693) irrespective of their age or of the stage which 
the disease had reached. 
Immediately on admission, after a history of the 
illness had been obtained, in which care was taken to 
establish the day of the illness, a specimen of sputum 
was secured. This was sent for bacteriological ex- 
amination with a view to finding the organism present 
and, should this prove to be a pneumococcus, to what 
type it belonged. 
After the specimen of sputum had been obtained, 
treatment with M. & B. 693 was instituted. The 
initial dosage consisted of four tablets (2 gms.) 
40. 
followed four hours later by a similar dose. After 
this, two tablets (1 gm.) were given till fourteen to 
sixteen tablets (7 -8 gms.) had been given. The sub- 
sequent dosage was varied with a view to noting the 
effects of various total dosages of the drug. Four 
cases received less than a total of eighteen tablets 
(9 gms.); sixteen cases were given eighteen to 
twenty -six tablets (9 -13 gms.); eleven,twenty -seven 
to thirty tablets (132 -15 gms.); twenty -two cases 
thirty -one to thirty -six tablets (152 -l8 gms.); eleve 
thirty -seven to fifty tablets (182 -25 gms.); ninetee 
cases received over 25 gms. 
In cases where oxygen was thought advisable in 
the early stages, it was given freely by means of a 
nasal catheter. 
Sedatives were administered as the need for them 
arose. In some cases a local application, such as 
anti- phlogistine, was applied to the chest to relieve 
pain in the early days of the illness. 
During the administration of the drug, sulphur - 
containing foods, such as eggs, were avoided, as were 
such aperients as magnesium sulphate. 
Throughout the course of treatment watch was 
kept for the appearance of toxic symptoms and efforts 
p, 
41. 
were made to overcome them as they appeared. A white 
blood count was made on all patients on the day of 
admission and in most at an interval of not more than 
three to four days and again towards the tenth day 
after admission. 
Where complications arose, they were dealt with 
in the usual manner and in certain cases further doses 
of M. & B. 693 were administered. 
¡Physical examination of the chest was carried out at 
frequent intervals throughout the course of the diseas e. 
42. 
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TREPTOCOCCLL. 





Temp. well after L. & B Mite Blood Count 
Toxic 






Tablets 1 day 3 -5 Later 
James C. 
H 16 25 4 ì,: L 20 . 8 7,800 5,200 - - 13 20 



















19 3 L L L 44 24 14 
Jeanette IcB.30 
E 5 
2 g L L 32 36 20 13,000 8, GUO 9 - 26 
Mrs Jane S. 
10 26 
1 R L L 52 Temp. did 
















- & B 
Temp. fell 1-)fter id &: B ',7hite Blood Count 
Toxic 




hours T ,,.blets i day 3 -5 Later 
Catherine T . 
3 
7 
18 1pì 16I 
3 
L L L 42 42 28,100 9,600 - - 18 24 
Joseph L. 7_?_ 18 &2I T L L y 30 24 10 11,000 5,000 - - 17 
James F. 
B 15 
I & 6 
2 
T L L 60 48 26 12,400 16,400 - - 14 20 
R. 
B 18 44 
1 6 20 
22' ' 
1 
R L L I 84 48 30 7,200 ,600 Cyanosis Temp. rose 
6th 
day, given? _' &F693 ri








2;_ & B 
Temp. fell, after í,í & B White Blood Count 
Toxic 








4 L 36 24 10 12,000 - - n 10 days 
Robert B. 
G 7 43 2 R L L 65 22 
Axillary adenitie 
prob ble cruse of 
rise in temp. 
Further 41 tablets 
M & B 6 93 
28 34 
Thomas McH. 
B 17 14 4 : L L 13 24 13 18,000 9,100 16 26 
Magn1s 
R 19 4 T L L 39 24 10 10,000 .6 , 300 15 24 




R L L 
78 12 ¡ 12 20,200 19,400 11 21 
Joseph P. 












í, rs Alen W 
D 10 
, 56 1 R L L 32 36 22 14,000 15 19 
James G. 
E 4 
21 2 it L L 26 24 10 8,400 8,000 10 13 
Andrew G . 46 2 L L L 32 24 18 7,500 500 
_ 
23,600 , 6 11 200 Temp. 
rose 3 days 
later -- no res- 
ponse I',_ & B 693. 










A 11 3 L L L 28 10 14,000 16 21 
51a. 
NOT TYPED Contd . 




, & B 
Temp. fell after & B White Blood Count 
Toxic 




hours Tablets 1 day 3 -5 Later 
Lindsey R. 
3 81 ï L L L 19 9 8 7,400 9,600 












1 ij: i:.fa7Yt.rrf f Sï.Cy _,i...a..a.. _- J 3.1 
i 
Tf l 
31 S 3i 
A, 
110 
tr .+f,,, a. 
Mi 4 
4 
I,.24 Ì: . 
L 1-1-- I 
1 . 
1 .. 00 } r 










Walter S. Case Letter: G 9. 
Age: 55 years. Sex: Male. 
Admitted 13.3.39. Day of Illness: Third. 
History: Patient has had a cold for past week. On 
morning of 11.3.39 had severe pain in 
right side of chest. 
Examination of Chest: Diminished expansion of right 
side. Dullness of right lower lobe, 
with coarse friction. Breath sounds 
inaudible. 
Sputum: Type 8 Pneumococcus. 
On 
Admission 
Treatment with M & B 693 






104 p. min, 









White Blood Count: On admission, 11,000 per c.cm. 
20.3.39, 14,400 per c.cm. 
X -ray: Pneumonic consolidation of right base. 
25.3.39: Fluid at right base. 
V. 3: B. 693: Total dosage - 101 tablets - 50.5 gms . 
Fall in temperature after 12 tablets. 
Complications: Temperature had a tendency to remain 
above normal for ten days. Fluid was found 
to be present at right base, and this was 
removed. Patient made an uninterrupted 
recovery. Fluid sterile. 
Discharge 16.4.39, after 34 days in hospital. 
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Name: Margaret McL. Case Letter: A 10. 
Age: 36 years. Sex: Female. 
Admitted 28.12.38. Day of Illness: Third. 
History: Two days before admission felt out of sort 
and in the evening had a rigor followed 
by profuse sweating. A few hours later 
had a pain in the right side of her ches 
and a frequent painful cough. 
Examination of Chest: Increased vocal fremitus in 
the right upper lobe. Diminished bron- 
chial breathing and a few crepitations. 
Increased vocal resonance. 
Sputum: Type IV. 
On 
Admission 
Treatment with M & B 693 






120 per min. 









White Blood Count: On admission, 15,800, per c.cm. 
X -ray: Patch of consolidation in upper part of right 
lung. 
4.1.39: Confirmed pneumonia. 
M. & B. 693: Total dosage - 28 tablets - 14 grins. 
Temperature fell by lysis on the 9th day of 
illness. 
Toxic Symptoms: Violent sickness after the second da 
drug discontinued. 
Discharged 21.1.39, having been out of bed from 16th 
day. 
Duration of stay in hospital - 24 days. 
56. 
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Daniel Y. Case Letter: G 2. 
Age: 44 years. Sex: Male. 
Admitted 15.5.39. Day of illness: 4th. 
History: Well till seven days ago when he felt sick 
and dizzy. Woke next morning feeling 
sore all over and had a shivering fit. 
Three days ago developed pain in chest. 
Examination of Chest: Impaired percussion of right 
lower lobe. Breath sounds faint. In- 
creased vocal resonance, and friction 
raies. 
Sputum: Type 14. 
On 
Admission 
Treatment with M & B 693 
After 24 hrs. After 48 hrs 
Temperature 101 °F. 97.2 98.2 
Pulse 110 p. min. 96 96 
Respiration 30 p. min. 26 30 
Blood Pressure 110/72 
57 . 
White Blood Count: On admission, 9.000 per c.cm. 
31.5.39, 4,600 per c.cm. 
X -ray: 18.5.39 - Consolidation and some fluid at 
right base. 
30.5.39 - Unresolved pneumonia; fluid presen 
M. & B. 693: Total dosage - 70 tablets - 35 grms. 
Temperature fell after 10 tablets, but varied 
for two days after. 
Complications: The temperature rose on 29.5.39; the 
chest was explored,with the removal of 20 ozs 
fluid, containing B. Proteus. 
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Name: James I. Case Letter: K 5. 
Age: 15 years. Sex: Male. 
Admitted 11.4.39. Day of illness: 1st. 
History: On day of admission complained of pain in 
left side, while at work. 
Examination of Chest: Restricted movement and dull- 
ness at left base. Bronchial breathing 
with fine crepitations, with friction 
above this. 
Sputum: Type 19. 
On 
Admission 
Treatment with M & B 693 
After 24 hrs. After 48 hrs. 
Temperature 101 °F. 
Pulse 116 p. min. 
Respiration 36 p. min. 








White Blood Count: On admission, 7,800 per c.cm. 
M. & B. 693: Total dosage - 18 tablets - 9 grms. 
Fall in temperature after 8 tablets, i.e. 8 
hours after admission. 
Discharge 25.4.39 to Convalescent Home after 14 days 
in hospital. UD on 10th day. 
Name: 
60. 
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Mrs Jenny E. Case Letter: K 10. 
Age: 38 years. Sex: Female. 
Admitted 21.6.39. Day of illness: 3rd. 
History: On 19.6.39 patient had a shivering fit and 
pain in the back. The pain spread to th 
abdomen and she was sent to Hospital as a 
surgical emergency. 
Examination of Chest: Limitation of movement on 
right side. Dullness of middle right 
lobe with bronchial breath sounds. 
Sputum: Type 13. 
On 
Admission 
Treatment with M & B 693 






120 p. min. 









White Blood Count: On admission, 12,000 per c.cm. 
26.6.39, 11,200 per c.cm. 
X -ray: Inflammatory process of right lower lobe in 
upper part. 
N. & B. 693: Total dosage - 80 tablets - 40 grms. 
Fall in temperature on 8th day. 
Toxic Symptoms: Vomiting, slight cyanosis. 
Duration of stay in Hospital - 14 days. 
Discharged 4.7.39: not up. 
Name: 
62. 
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Peter B. Case Letter: L 2. 
Age: 15 years. Sex: Male. 
Admitted 6.6.39. Day of illness: 2nd. 
History: On morning before admission was suddenly 
sick; this was followed in the evening 
by a pain in the right side on coughing; 
blood -stained sputum. 
Examination of Chest: Diminished expansion and dull- 
ness at right base. Bronchial breathin 
with crepitations. Vocal resonance 
increased. 








122 p. min. 
38 p. min. 
112/64 
Treatment with M B 693 








White Blood Count: On admission, 30,000 per c.cm. 
F. B. 693: Total dosage - 46 tablets - 23 grms. 
Fall in temperature after 12 tablets, 
i.e. 18 hours. 
Complications: Temperature rose again 24 hours later 
and fell in 48 hours. 
Discharged on 23.6.39 to Convalescent House, after 17 
days in hospital. 
n on 14th day. 
64. 
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Name: James L. Case Letter: L 3. 
Age: 57 years. Sex: Male. 
Admitted 6.6.39. Day of illness: 2nd. 
History: Two days before admission had headaches and 
general malaise. On day before admissio 
rain in right side of chest: sputum 
blood- tinged. 
Examination of Chest: Barrel -shaped; impaired move 
ment, right side of chest; harsh vesicu- 
lar breathing in upper part of right lung 
with fine crepitations; increased vocal 
resonance in this area. 
Sputum: Type 5. 
On 
Admission 
Treatment with M & B 693 






100 p. min. 







White Blood Count: On admission. 24,800 per c.cm. 
X -ray: Partial consolidation of upper of right 
lung field. 
M. & 13. 693: Total dosage - 42 tablets - 21 grms. 
Fall in temperature after 6 tablets, i.e. 
within 20 hours. 
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Mary S. Case Letter: B 13. 
Age: 21 years. Sex: Female. 
Admitted 21.12.38. Day of illness: 4th. 
History: Three days ago felt shivery and this was 
followed by a sharp pain in the right 
side of the chest, and a frequent, pain- 
ful cough. 
Examination of Chest: Dullness at right base with 
diminished bronchial breathing and 
occasional crepitations. 








120 p. min. 
40 p. min. 
110/70 
Treatment with M & B 693 





White Blood Count: On admission, 17,000 per c.cm. 
24.12.38, 14,000 per c.cm. 
M. & B. 693: Total dosage - 48 tablets - 24 grms. 
Fall in temperature after 12 tablets, i.e 
within 24 hours. 
Discharged 4.1.39 after 14 days in hospital. 
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Thomas D. Case Letter: C 9. 
Age: 64 years. 
Admitted 14.12.38. 
Sex: Male. 
Day of illness: 1st. 
History: Generalised aches and pains for three days, 
followed by right sided chest pain and 
cough shortly before admission. 
Examination of Chest: Impaired movement and dull 
percussion note at right base, with 
bronchial breathing. 
Sputum: Type 9. 
On 
Admission 
Treatment with M & B 693 






100 p. min. 









White Blood Count: On admission, 13,400 per c.cm. 
17.12.38, 14,000 " " 
26.12.38, 10,400 " " 
X -ray: Pneumonia of right lower lobe. 
28.1.39: Delayed resolution of an inflamma- 
tory process. 
Y. & B. 693: Total dosage - 16 tablets - 8 grins. 
Fall in temperature after 10 tablets. 
Toxic symptoms: Vomiting. Treatment stopped. 
Complications: Urethral stricture and papilloma of 
bladder revealed by cystoscopic examination. 
Discharged 17.2.39 after 61 days in hospital. 
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Wesley J. Case Letter: C 5. 
Age: 14i years. Sex: Male. 
Admitted 30.1.39. Day of illness: 3rd. 
History: Two days ago developed pain across front 
of chest, made worse on coughing, and 
cough produced a green frothy sputum. 
Examination of Chest: Impaired expansion and per- 
cussion note at right base, with faint 
breath sounds and fine crepitations. 
Sputum: Type 16. 













White Blood Count: On admission, 13,000 per c.cm. 
1.2.39, 7,200 " 
4.2.39, 6,600 " " 
M. ck B. 693: Total dosage - 30 tablets - 15 grms. 
Fall in temperature after 10 tablets, i.e 
within 20 hours. 
Discharged on 25.2.39, after 26 days in hospital. 
Ua on 18th day. 
Name: 
72. 
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Andrew L. Case Letter: 





Day of illness: 4th. 
Three days previous to admission, complained 
of sharp stabbing pain in left side of 




of Chest: Stony dullness at left base; 





Treatment with M B 693 
After 24 hours. After 48 hrs. 
Temperature 103.2 °F. 99.2 97.2 
Pulse 110 p. min. 88 86 
Respiration 42 p. min. 24 30 
Blood Pressure 114/70 
I 3 . 
White Blood Count: On admission, 30,000 per c.cm. 
14.3.39, 9,200. tt rr 
X -ray: 13.3.39 - Inflammatory process of left base, 
unresolved. 
Y. & B. 693: Total dosage - 30 tablets - 15 firms. 
Fall in temperature after 12 tablets. 
Toxic Symptoms: Vomiting on first day of administrati 
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Lawrence A. Case Letter: D 5. 
Age: 36 years. Sex: Male. 
Admitted 13.1.39. Day of illness: 1st. 
History: Several previous attacks of pneumonia; 
had a cold for fourteen days: two days 
before admission, fractured 11th rib; 
on day of admission, severe chest pain. 
Examination of Chest: Dullness both bases; breath 
sounds faint; fine crepitations both 
bases. 
Sputum: Type 9. 
On 
Admission 
Treatment with <. «, B 693 
After 24 hrs.'  After 48 hrs 
Temperature 100 °F. 99.6 97 
Pulse 110 p. min. 96 80 
Respiration 30 p. min. 30 30 
Mood Pressure 120/60 
ti 
75. 
White Blood Count: On admission, 19,800 per c.cm. 
.1.(-ray: Consolidation of right lower lobe. 
30.1.39: Lung field clear; right costa - 
phrenic angle obscured. 
M. & B. 693: Total dosage - 34 tablets - 17 grms. 
Fall in temperature after 20 tablets. i.e 
24 hours after admission. 
Toxic symptoms: Cyanosis. 
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William B. Case Letter: D 8. 




Day of illness: 4th. 
Patient well till four days before admis- 
sion, when he had a shivering fit. 
Next day he complained of pain in the 
middle of the back, aggravated by cough- 
ing and breathing. 
Examination of Chest: Dullness in right axilla with 
bronchial breath sounds. 
Sputum: Type 12. 
On 
Admission 
Treatment with M Ú. B 693 






140 p. min. 









White Blood Count: On admission, 25,400 per c.' . 
25.11.39, 9,800 rr n 
X -ray: Consolidation of right middle lobe. 
25.11.38 - clear. 
M. & B. 693: Total dosage - 32 tablets - 16 ,grins. 
Fall in temperature after 10 tablets, i.e. 
within 24 hours. 
Discharged on 25.11.39 after 1e days in hospital. 
LE on 13th day. 
Name: 
78. 
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James McC. Case Letter: K 1. 
Age: 19 years. Sex: Male. 
Admitted 2.5.39. Day of illness: 4th. 
History: Pain in left side of chest since 29.4.39. 
Examination of Chest: Diminished movement of left 
side; dullness and bronchial breathing, 
with fine crepitations. 
Sputum: Type 7. 
On 
Admission 
Treatment with IVI ?c B 693. 






110 p. min. 






White Blood Count: On admission 8,600 per c.cm. 
X -ray: 8.5.39 - Chest negative. 
M. & B. 693: Total dosage - 26 tablets - 13 grins. 
Fall in temperature after 10 tablets i.e. 
within 24 hours. 
Discharged 15.5.39 after 14 days in hospital. 
a ten days after admission. 
80. 
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Name: Alfred D. Case Letter: F 6. 
Age: 51 years. Sex: Male. 
Admitted 2.10.38. Day of illness: 1st. 
History: Wakened early on morning of admission with 
severe pain in the left side of chest, 
followed shortly by a slight cough, 
bringing up blood- tinged, frothy sputum. 
Examination of Chest: Restricted movement, with im- 
paired percussion note at left base; 
also bronchial breathing with a few fine 
crepitations. 
Sputum: Type 4. 
On 
Admission 
Treatment with M & B 693 
After 24 hrs. After 48 hrs. 
Temperature 102.50F. 102.6 99 
Pulse 100 p. min. 94 94 
Respiration 26 p. min. 38 30 
Blood Pressure 104/76 
81. 
White Blood Count: On admission, 17,000 per c.cm. 
6.10.38, 7,000 " " 
X -ray: Consolidation of lower half of left lung fiel 
11.10.38: Inflammatory process fast resolvin 
M.& B. 693: Total dosage - 26 tablets - 13 grins. 
Fall in temperature after 8 tablets, i.e. 
after 24 hours' administration, though treat- 
ment not started till 3.10.38. 
Discharged 28.10.38 after 26 days in hospital. 
a on 21st day. 
Name: 
82. 
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Alexander G. Case Letter: M 4. 
Age: 44 years. Sex: Male. 
Admitted 25.11.38. Day of illness: 3rd. 
History: Three days before admission developed pain 
in the epigastrium; next morning had 
left -sided pain and cough, followed by 
constant severe headache. 
Examination of Chest: Dullness on left side of chest 
with bronchial breathing; vocal fremitus 
and vocal resonance increased. 
Sputum: Type 5. 
On 
Admission 
Treatment with M B 693 






108 p. min. 










White Blood Count: On admission - 15,800 per c.cm. 
29.11.38 - 11,000 " " 
2.12.38 - 6,200 " " 
M. & B. 693: Total dosage - 22 tablets - 11 grms. 
Fall in temperature after 10 tablets. 
Toxic Symptoms: Mild vomiting. 
Discharged 21.12.38 after 26 days in hospital. 
ER on 18th day. 
84. 
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Case Letter: K 2. 
Sex: Male. 
Day of illness: 2nd. 
History: On 22.4.39 patient developed a pain in the 
small of the back, with a cough which 
aggravated the pain, and also produced a 
rusty sputum. 
Examination of Chest: Restricted movement of right 
base; dullness of right lower lobe, with 
distant bronchial breathing. 
Sputum: Type I. 
On 
Admission 
Treatment with M c B 693 
After 24 hrs. After 48 hrs. 
Temperature 103 °F. 99 97.4 
Pulse 98 per min. 92 88 
Respiration 24 p. min. 25 22 
Blood Pressure 112/62 
85. 
White Blood Count: On admission, 16,800. 
X -ray: 3.5.39 - Old standing pleural thickening. 
M. & B. 693: Total dosage - 50 tablets - 25 arms. 
Fall in temperature after 14 tablets. 
Discharged 9.5.39 to Convalescent Home after 16 days 
in hospital. 
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Name: William D. Case Letter: K 4. 
AS,!: 60. Sex: Male. 
Admitted 11.4.39. Day of illness: 1st. 
History: On evening before admission, shivering and 
vomiting; in the early hours of this 
morning pain in the upper half of left 
chest, with cough. 
Examination of Chest: Limitation of movement at lef 
base, with imnaired percussion. Fricti 
heard at this area and harsh vesicular 
breathing. 





On Treatment with M B 693 
dmission after 24 hrs. After 48 hrs. 
103 °F. 
116 p. min. 










White Blood Count: On admission, 21,000 per c.cm. 
X -ray: 13.4.39 - Consolidation below left hilum. 
M. & B. 693: Total dosage - 70 tablets - 35 grms. 
Fall in temperature after 20 tablets, i.e. 
within 24 hours. 
Discharged 22.4.39 to Convalescent Home after 12 days 
in hospital. 
Utz on 11th day. 
88. 
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Name: James N. Case Letter: L 1. 
Age: 30 years. Sex: Hale. 
Admitted 7.6.39. Day of illness: 2nd. 
History: Cough for two days before admission, with 
headache and general malaise. 
Examination of Chest: Pleural rub over right lung 
anteriorly and inferiorly. 
Sputum: Type I. 
On 
Admission 
Treatment with ;; B 693 






120 p. min. 






White Blood Count: On admission, 21,400 per c.cm. 
M. & B. 693: Total dosage, 42 tablets - 21 firms. 
Fall in temperature after 22 tablets i.e. 
24 hours after admission. 
Discharged 28.6.39, after 12 days in hospital. 
n on 10th day. 
90. 
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Name: Charles C. Case Letter: L 4. 
Age: 26 years. Sex: Male. 
Admitted 6.6.39. Day of illness: 5th. 
History: On 2.6.39 had severe pain in left side of 
chest, with giddiness and sweating. On 
day before admission had a cough and 
blood -stained sputum. 
Examination of Chest: Diminished movement and dull- 
ness over left base: bronchial breathing 
with crepitations. 
Sputum: Type I. 
On Treatment with M & B 693 






112 D. min. 









White Blood Count: On admission, 12,800 per c.cm. 
B. 693: Total dosage - 48 tablets - 24 firms. 
Fall in temperature after 14 tablets. 
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Name: Alexander M. Case Letter: D 3. 
Age: 31 years. Sex: Male. 
Admitted 22 .1.39. Day of illness: 2nd. 
History: Patient has had a cold for seven days. 
Yesterday he had several shivering fits 
and late last night he took a severe 
pain in the left side of his chest. 
Examination of Chest: Dullness of left lower lobe; 
increased vocal fremitus and vocal 
resonance; diminished breath sounds. 








120 p. min. 
32 p. min. 
112/70 
Treatment with M , B 693 








White Blood Count: On admission, 24,000 per c.cm. 
23.1.39, 35,000 " n 
X -ray: 23.1.39 - Left lower lobe consolidation. 
2.2.39 - Consolidation outwards and down to 
left hilum. 
6.3.39 - Clear. 
M. & B. 693: Total dosage - 33 tablets - 16.5 grms. 
Fall in temperature after 22 tablets, i.e. 
36 hours. 
Discharged 18.2.39 after 27 days in hospital. 
Up, on 15th day. 
1, 
94. 
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Name: Catherine P. 
Ao.e' 21 years. 
Admitted 23.11.38. 
Case Letter: 1. 
Sex: Female. 
Day of illness: 3rd. 
History: Two days before admission felt out of sorts 
and shivery. This was followed in a few 
hours by a sharp pain in the left side of 
the chest. 
Examination of Chest. Dullness at left base with 
bronchial breath sounds; increased vocal 
fremitus and resonance. 
Sputum: Type I Fneumococcus. 
On 
Admission 
Treatment with M ?. B 693 






130 p. min. 









White Blood Count: On admission, 13,800 per c.cm. 
K -ray: Consolidation of left lower lobe. 
B. 693: Total dosage - 32 tablets - 16 firms. 
Fall in temperature after 15 tablets, i.e. 
after 3 days - tablets being given only one 
4- hourly. 
Discharged 10.12.38, after 18 days in hospital. 
to on 11th day. 
N ame : 
96. 
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Annie OID. Case Letter: E 9. 
Age: 19 years. Sex: Female. 
Admitted 10.3.39. Day of illness: 3rd. 
History: Two days prior to admission patient felt 
shivery and developed pain_ in right side 
of chest. 
Examination of Chest: Dullness over right lower lobe; 
high pitched bronchial breathing in lower 
part of right lobe. 





On Treatment with ir_ B 693 
Admission After 24 hrs. After 4C hrs. 
102.8 °F. 99.6 
130 p. min. 112 






White Blood Count: On admission, 19,600 per c.cm. 
14.3.39, 16,000 " " 
X -ray: 5.4.39 - Clear. 
M. & B. 693: Total dosage - 32 tablets - 16 grrfls. 
Fall in temperature after 16 tablets, i.e. 
24 hours later. 
Discharged on 7.4.39, after 39 days in hospital. 
IIa on 19th day. 
98. 
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Name: Mrs Cissie EcA. Case Letter: B 12. 
Age: 30 years. Sex: Female. 
Admitted 22.2.39. Day of illness: 3rd. 
History: Two days before admission felt out of sorts 
and was troubled by a sharp pain in the 
right side of the chest. The following 
day the pain was much worse and aggravate 
by coughing and breathing; also had a 
sticky blood- stained sputum. 
Examination of Chest: Dullness on right side of ches 
with bronchial breathing; vocal fremitus 
and vocal resonance increased. 
Sputum: Type II Pneumococcus. 
On 
Admission 
Treatment with M & B 693 






126 p. min. 










White Blood Count: On admission, 16,000 per c.cm. 
. & B. 693: Total dosage - 10 tablets - 5 grins. 
Fall in temperature after 10 tablets, i.e. 
24 hours. 
Complication: Seven months pregnant, but the foetus 
had good heart beats throughout. 
Discharged 7.3.39 after 13 days in hospital. 
UP on 10th day. 
100. 
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Name: John McB. Case Letter: A 9. 
Age: 22 years. Sex: Male. 
Admitted 5.2.39. Day of illness: 3rd. 
History: Two days before admission felt out of sorts 
and shivery. This was followed at night 
by a sharp pain in the right side of the 
chest, later associated with a dry, pain 
ful cough. 
Examination of Chest: Dullness on percussion and 
bronchial breathing at right base. 
Vocal resonance increased. 
Sputum: Type II Pneumococcus. 
On 
Admission 
Treatment with M . B 693 






112 p. min. 









White Blood. Count: On admission, 16,200 per c.cm. 
X -ray: Pneumonic consolidation of right lower lobe. 
M. & B. 693: Total dosage - 36 tablets - 18 firms. 
Fall in temperature after 24 tablets , i . e . in 
36 hours. 
Discharged 21.2.39 to Convalescent Home after 16 days 
in hospital. 
102. 
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Name: Henry R. 
Age: 27 years. 
Admitted 5.2.39. 
Case Letter: A 8. 
Sex: Male. 
Day of illness: 3rd. 
History: Two days before admission, contracted a 
severe attack of "influenza ", with cough 
and pain in the chest. 
Examination of Chest: Impaired movement with dullness 
on percussion of left base. Vocal fremi- 
tus and vocal resonance increased; 
bronchial breathing. 




-After 24 hrs . 
hM &B693. 






130 p. min. 









White Blood Count: On admission, 24,000 per c.cm. 
8.2.39, 20,000 " n 
11.2.39, 26,000 " ti 
X -ray: Consolidation of left base. 
B. 693: Total dosage - 36 tablets - 18 grms. 
Fall in temperature after 16 tablets, i.e. 
within 24 hours. 
Complication: Four days after temperature had fallen, 
it rose to 103 °F. and it was found that the 
pneumonia had extended to the right lower 
lobe. In spite of another course of Y. & B1 
693, i.e. 84 tablets given as two tablets 
4- hourly, the temperature continued to swing 
for eight days and the patient was desperate- 
ly ill. After the eighth day the tempera- 
ture settled, all his symptoms cleared and 
he made an uninterrupted recovery. 
Discharged 24.3.39 after 47 days in hospital. 
a on 42nd day. 
104. 
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Name: Robert T. Case Letter: A 7. 
Age: 46 years. Sex: Male. 
Admitted 1.2.39. Day of illness: 2nd. 
History: On day before admission felt shivery and 
"out of sorts "; later was seized by a 
sharp pain in the left side of chest, 
followed by a hard, Painful cough, bring- 
ing up small quantities of reddish sticky 
sputum. 
Examination of Chest: Dullness at left base and 
slightly impaired note below right clavicle. 
High pitched bronchial breathing at left 
base; diminished bronchial breath sounds 
at right upper lobe. 
Cardio- Vascular System: Pulse bounding in character, 
with numerous extra -systoles; vessel wall 
palpable. Heart - apex beat in 6th space, 
outwith mid- clavicular line. 




Treatment with M & B 693 
After 24 hrs. After 48 hrs. 
Temperature 100.4 °F. 100 97.8 
Pulse 132 p. min. 114 104 
Respiration 52 p. min. 40 40 
Blood Pressure 120/70 
White Blood Count: On admission, 24,000 per c.cm. 
7.2.39, 14,000 " " 
X -ray: 7.2.39 - Consolidation of right upper and left 
lower lobes. 
M. & B. 693: Total dosage 28 tablets - 14 grins. 
Fall in temperature within 48 hours, i.e. 
after 16 tablets. 
Complications: Hypertrophy and dilatation of heart. 
Death 8.2.39. 
Post -mortem: Double pneumonia, hypertrophy and 
dilatation of the heart, with an old -standing 
pericarditis. 
106. 
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Name: Angus MacD. Case Letter: A 4. 
Age: 24 years. Sex: Yale. 
Admitted 25.1.39. Day of illness: 5th. 
History: Five days ago patient was seized by severe 
pain in left side of the chest, made 
worse by breathing and coughing. 
Examination of Chest: Dullness on percussion over left 
infra -clavicular region; bronchial breath 
sounds; vocal fremitus and resonance in- 
creased. 
Sputum: Type II. 
On 
Admission 
Treatment with _,_ B 693 
After 24 hrs. After 48 hrs. 
Temperature 100.6 °F. 97.8 97 
Pulse 88 p. min. 80 80 
Respiration 24 p. min. 30 20 
Blood Pressure 130/62 
107. 
White Blood Count: On admission, 13,800 per c.cm. 
X -ray: Consolidation of upper part of upper left 
lobe. 
M. & B. 693: Total dosage - 28 tablets - 14 firms. 
Fall in temperature after 12 tablets, i.e. 
within 12 hours of admission. 
Discharged 15.2.39 after 21 days in hospital. 
Up on 12th day. 
N ame : 
108. 
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Frank D. Case Letter: F 2. 
Age: 18 years. Sex. Male. 
Admitted 7.1.39. Day of illness: 4th. 
History: Four days ago patient developed pain in 
right side of chest; pain worse on cough- 
ing; sputum blood- stained. 
Examination of Chest: Dullness of lower part of right 
lower lobe; high pitched bronchial breath- 
ing. 
Sputum: Type II. 
On 
Admission 
Treatment with M & B 693 






120 p. min. 









White Blood Count: On admission. 15,000 per c.cm. 
13.1.39, 5,400 " 
r 
X -ray: 20.1.39 - Pneumonia not resolved. 
Y. 6c B. 693: Total dosage - 32 tablets - 16 firms. 
Fall in temperature after 10 tablets, i.e. 
in 12 hours. 
Discharged 26.1.39 after 19 days in hospital. 
R on 16th day. 
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Name: Anthony G. 
w 
ó 
Case Letter: E 12. 
Age: 37 years. Sex: Liale. 
Admitted 14.1.39. Day of illness: 2nd. 
History: Two days before admission, shivering and 
vomiting; next day pain developed in 
right side of chest. 
' Examination of Chest: Dullness of right lower lobe; 
High pitched bronchial breathing. 
Sputum: Type II. 
On 
Admission 
Treatment with I:)i _ <. B 693 
After 24 hrs. After 48 hrs. 
Temperature 100°F. 97.8 97.2 
Pulse 104 p. min. 92 76 
Respiration 30 p. min. 26 22 
Blood Pressure 120/70 
White Blood Count: On admission, 
19.1.39, 
14.2.39, 
8000 per c.cm. 
9,200 " " 
6,000 " " 
M. & B. 693: Total dosage - 34 tablets - 17 grins. 
Fall in temperature after 12 tablets, i.e. 
within 24 hours. 
Discharged 24.2.39 after 28 days in hospital. 
Uo on 18th day. 
112. 
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Name: Robert W. 
s 
r 
Case Letter: E 11. 
Age: 66 years. Sex: Male. 
Admitted 28.1.39. Day of illness: 4th. 
History: Bronchitis all winter; pain in left side 
of chest for last three days. 
Examination of Chest: Impairment of percussion note 
at left base; bronchial breathing and 
crepitations. 
Sputum: Type II. 
On 
Admission 
Treatment with 11 w B 693 
After 24 hrs. After 48 hrs. 
Temperature 99 °F. 97 97 
Pulse 110 p. min. 108 92 
Respiration 40 p. min. 30 32 
Blood Pressure 120/60 
113. 
White Blood Count: On admission, 31,000 per c.cm. 
13.2.39, 8,800 n n 
X -ray: 6.3.39 - Unresolved pneumonia. 
M. & B. 693: Total dosage - 36 tablets - le grms. 
Fall in temperature after 20 tablets. 
Note: Treatment not started until two days 
after admission, when temperature 
rose to 101 °F. 
Complications: Extensive bronchitis and fibrosis; 
pneumonia still unresolved six weeks later. 
Discharged 26.2.39 to Convalescent Home. after 29 days 
in hospital. 
Ua on 22nd day. 
114 . 
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Name: John D. Case Letter: E 8. 
Awe: 16 years. Sex: Male. 
Admitted 1.4.39. Day of illness: 4th. 
History: Patient got wet at work, four days ago. 
Next day felt stiff and shivery and, 
twenty -four hours later. had a pain in 
his chest. 
Examination of Chest: Some dullness at left base, 
with bronchial breath sounds. 
Sputum: Type II. 
On 
Admission 
Treatment with M x B 693 






110 D. min. 









White Blood Count: On admission, 13,800 per c.cm. 
4.4.39, 7,030 n n 
B. 693: Total dosage - 36 tablets - 18 firms. 
Fall in temperature after 20 tablets, i.e. 
within 36 hours. 
Discharged.on 1'7.4.39 to Convalescent Home, after 
16 days in hospital. 
EE on 12th day. 
116. 
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Name: Andrew H. Case 6. 
Age: 13 years. Sex: Male. 
Admitted 27.5.39. Day of illness: 2nd. 
History: Patient felt ill while at school, yesterday 
In the afternoon he had a pain in the 
right side of his chest. 
Examination of Chest: Dullness in right axilla and 
upper Dart of right chest; friction- 
vesicular breathing. 
Sputum: Type II. 
On 
Admission 
Treatment with M & B 693 
After 24 hrs. After 48 hrs. 
Temperature 104°F. 100 97.8 
Pulse 140 p. min. 110 80 
Respiration 40 p. min. 28 24 
Mood Pressure 98/38 
117. 
White Blood Count: On admission, 12,400 per c.cm. 
31.5.39, 8,200 " n 
X -ray: 9.6.39 - Almost complete resolution. 
M. & B. 693: Total dosage - 40 tablets - 20 grms. 
Fall in temperature after 14 tablets, i.e. 
within 24 hours. 
Discharged 15.6.39, after 19 days in hospital. 
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Name: John T. Case Letter: D 9. 
Abe: 28 years. Sex: Male. 
Admitted 7.12.38. Day of illness: 3rd. 
History: Two days before admission patient had a 
shivering fit. This was followed by a 
sharp pain in the right side of the chest, 
ar;gravated by coughing and breathing. 
Examination of Chest: Dullness at right base, with 
bronchial breathing; vocal fremitus and 
resonance showed marked increase. 
Sputum: Type II. 
On 
Admission 
Treatment with M w B 693 
After 24 hrs. After 48 hrs. 
Temperature 102°F. 99.4 96.2 
Pulse 120 p. min. 110 88 
Respiration 38 p. min. 30 20 
Blood Pressure 78/52 
119. 
White Blood Count: On admission, 8,800 per c.cm. 
13.12.38, 6,700 " " 
X -ray: Pneumonic consolidation of right lower lobe. 
17.1.39: Chest clear. 
M. ¿: B. 693: Total dosage - 30 tablets - 15 grins. 
Fall in temperature after 14 tablets i.e. 24 
hours later. 
Discharged 20.12.38 after 14 days in hospital. 
Name: 
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Jessie R. Case Letter: D 6. 
Age: 16 years. Sex: Female. 
Admitted 12.1.39. Day of illness: 4th. 
History: Patient has had a cold for 14 days; four 
days ago had a pain in her chest. 
Examination of Chest: Dullness of left base: 
bronchial breathing heard below angle of 
scapula. 
Sputum: Type II. 
On 
Admission ,After 
Treatment with is& B 693 
24 hrs. After 48 hrs 
Temperature 101.2 °F. 98.4 97 
Pulse 136 p. min. 120 110 
Respiration 32 p. min. 28 22 
Blood Pressure 120/68 
121. 
White Blood Count: On admission, 14,000 per c.cm. 
23.1.39, 10,800. 
X -ray: Consolidation of left lower lobe. 
24.2.39 - Resolved. 
M. & B. 693: Total dosage - 32 tablets - 16 grms. 
Fall in temperature after 12 tablets, i.e. 
24 hours after admission. 
Discharged on 20.1.39 to Convalescent Home after 16 
days in hospital. 
122. 
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Name: Bernard McK. Case Letter: D 4. 
Age: 15 years. Sex: Male. 
Admitted 21.1.39. Day of illness: 1st. 
History: Feeling unwell for three days; pain starte 
in back of right side of chest this morn- 
ing. 
Examination of Chest: Impaired rercussion of right 
upper and middle lobes; harsh vesicular 
breathing with prolongation of expiration 
and a few fine crepitations. 
Sputum: Type II. 
On 
Admission 
Treatment with M ,. B 693 






120 p. min. 









White Blood Count: On admission, 20,000 per c.cm. 
3.2.39, 20,000 " " 
X -ray: Consolidation of right upper, mid and lower 
lobes. 
M. & B. 693: Total dosage - 32 tablets - 16 grms. 
Fall in temperature after 18 tablets - 
though treatment not commenced till 4th day 
of illness. 
Toxic Symptoms: Slight vomiting. 
Complication: Boils on buttocks. 
Discharged 28.2.39, after 38 days in hospital. 
Up. on 18th day. 
124. 
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Name: Charles A. Case Letter: D 1. 
Age: 22 years. Sex: Male. 
Admitted 28.2.39. Day of illness: 2nd. 
History: One night ago complained of shivering and 
this was followed shortly after by a 
pain in the left side of the chest, 
aggravated by coughing. 
Examination of Chest: Vocal fremitus increased; 
dullness over left lower lobe; bronchia 1 
breath sounds; increased vocal resonance. 
Sputum: Type II. 
On Treatment with M & B 693 






130 p. min. 






White Blood Count: On admission, 24,600 per c.cm. 
6.3.39, 10,400 " " 
M. & B. 693: Total dosage - 22 tablets - 11 grms. 
Fall in temperature 12 hours after adminis- 
tration, i.e. 10 tablets. 
Toxic Symptoms: Vomiting with stoppage of drug. 
Complications: Temperature rose again on 6th day 
for twenty -four hours; M. & B. 693 resumed 
and continued till 7.3.39 - 40 tablets being 
given. Tendency to vomit remained. 
Discharged on 13.3.39 after 13 days in hospital. 
Ua on 12th day. 
126. 
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Name: James B. Case Letter: C 4. 
Age 23 years. 
Admitted 30.1.39. 
Sex: ïale . 
Day of illness: 2nd. 
History: Pain in abdomen two days ago, followed by a 
cough next day. 
Examination of Chest: Diminished expansion at right 
base with impaired percussion note and 
bronchial breathing. 
Sputum: Type II. 
On 
Admission 
Treatment with M & B 693 






104 D. min. 









White Blood Count: On admission, 19,600 per c.cm. 
4.2.39, 8,600. 
M. & B. 693: Total dosage - 30 tablets - 15 grms. 
Fall in temperature after 14 tablets, i.e. 
32 hours after treatment commenced. 
Toxic Symptoms: Nausea and vomiting for two days. 
Discharged on 25.2.39 after 25 days in hospital. 
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Name: Mrs Jessie R. Case Letter: C 7. 
Age: 54 years. Sex: Female. 
Admitted 5.12.38. Day of illness: 2nd. 
History: Two days ago felt cold and shivery; next 
day had pain in right side of chest, 
associated with headache and vomiting. 
Later in the day patient collapsed. 
Examination of Chest: Dull percussion note at right 
side of chest with bronchial breathing 
and fine crepitations at right base. 
Sputum: Type II. 
On 
Admission 
Treatment with M & B 693 






140 p. min. 









White Blood Count: On admission, 18,030 per c.cm. 
13.12.38, 11,200 " " 
X -ray: Consolidation of right lower lobe with atelec 
tasis of upper lobe. 
29.12.3E: Resolving pneumonia. 
Y. & L. 693: Total dosage - 36 tablets - lF grms. 
Fall in temperature after 12 tablets, i.e. 
within 24 hours. 
Toxic symptoms: Cyanosis. 
Complications: Atelectasis of right upper lung lobe 
Discharged 7.1.39 after 34 days in hospital. 
Up on 22nd day. 
130. 
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Name: George R. Case Letter: C 8. 
Age: 51 years. Sex: Yale. 
Admitted 8.1.39. Day of illness: 6th. 
History: Not well since the New Year; four days 
ago loss of appetite and nausea; two 
days ago had a sharp pain in the left 
side - made worse on coughing. 
Examination of Chest: Impaired novement at left bas 
with impaired percussion note; also 
bronchial breathing with fine crepitatio 
in this area. 
Sputum: Type II. 
On 
Admission 
Treatment with i_ B 693 
After 24 hrs. After 48 hrs. 
Temperature 
¡ 100.4 °F. 97.4 97.8 
Pulse 104 p. min. 90 80 
Respiration 22 p. min. 28 24 
Blood Pressure, 98/64 
s 
131. 
White Blood Count: On admission, 17,000 per c.cm. 
19.1.39, 8,800 " n 
X -ray confirms consolidation. 
M. & B. 693: Total dosage - 20 tablets - 10 firme. 
Fall in temperature after 10 tablets, i.e. 
in 20 hours. 
Toxic Symptoms - Cyanosis: nausea. 
Discharged on 7.2.39 to Convalescent Home after 30 
days in hospital. 
UP on 22nd day. 
132. 
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Name: David B. Case Letter: C 11. 
Age: 62 years. Sex: ,. ale. 
Admitted 16.11.38. Day of illness: 4th. 
History: Pain in right side of chest for four days, 
a gravated by work, and a cou;rh which 
produced a white frothy spit. 
Examination of Chest: Diminished movement on the 
right side. with dullness over the right 
base. Bronchial breathing accompanied 
by coarse crepitations. 
Sputum: Type II. 
On 
Admission 
Treatment with II' B 693 






130 p. min. 









White Blood Count: On admission, 11,000 per c.cm. 
22.11.38, 7,200 " rr 
M. & B. 693: Total dosage - 23 tablets - 11.5 grms. 
Fall in temperature after 14 tablets. 
Toxic Symptoms: Vomiting with stopping of M. & B. 
693. 
Complications: Marked dehydration and extremely ill 
on admission, requiring two intravenous 
salines. 
Discharged on 12.12.38 after a stay of 26 days. 
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Thomas G. Case Letter: H 15. 
Age: 60 years. Sex: I.-ale. 
Admitted 26.12.38. Day of illness: 3rd. 
History: Has had a cough for the past three weeks. 
Breathlessness since 24.12.38. 
Examination of Chest: Diminished expansion of right 
side of chest; dullness of right middle 
and lower lobes; tubular breathing and 
increased vocal resonance. 
Sputum: Type II. 
On 
Admission 
Treatment with M & B 693 
After 24 hrs. After 48 hrs. 
Temperature 100 °F. 97.2 97 
Pulse 110 p. min. 82 74 
Respiration 28 p. min. 30 26 
Blood Pressure 120/72 
135. 
Mite Blood Count: On admission, 11,500 per c.cm. 
4.1.39, 12,000 " fr 
X -ray: 23.1.39 - Delayed resolution. 
13.2.39 - Still some obscurity. 
M. & B. 693: Total dosage - 68 tablets - 34 grins. 
Fall in temperature after 10 tablets. i.e. 
within 24 hours. 
Discharged 17.1.39 to Convalescent Home after 22 days 
in hospital. 
a on 13th day. 
Name: 
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Case Letter: H 12. 
Age: 15 years. Sex: 1.:ale. 
Admitted 29.1.39. Day of illness: 3rd. 
History: On 24.1.39 patient felt cold and shivery, 
had severe headache and felt sore all 
over. On 27.1.39 he developed pain in 
right side of chest. 
F.cnarination of Chest: Diminished expansion and dull- 
ness of right lower lobe; bronchial 
breathing and increased vocal resonance 
in this area. 
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On Treatment with M & g 693 
Admission After 24 hr. ̀ After 48 hrs . 
1020y. 
94 p. win. 










White Blood Count: On admission, 10,000 per c.cm. 
10.2.39, 10,800. 
Y. &. B. 693: Total dosage - 30 tablets - 15 firms 
Fall in temperature after 12 tablets. 
Discharged 23.2.39 after 25 days in hospital. 
R on 12th day. 
138. 
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Name: Charles S. Case Letter: H 10. 
Age: 24 years. Sex: Female. 
Admitted 6.3.39. Day of illness: 3rd. 
History: Off colour for about one week but con- 
tinued work. On 7.3.39 had a shivering 
attack. 
Examination of Chest: Diminished movement of left 
lower lobe; dullness in this area dnd 
bronchial breathing. 
Sputum: Type II. 
On 
Admission 
Treatment with IM? B 693 






120 p. min. 









White Blood Count: On admission, 14,000 per c.cm. 
9.3.39, 14,000 " u 
X -ray: 23.3.39 - Fluid at right base. 
M. & B. 693: Total dosage - 72 tablets - 36 grins. 
Fall in temperature after 16 tablets, but 
continued rather irregular. 
Complication: On 23.3.39 developed purulent fluid at 
right base, which necessitated surgical 
operation. 
140. 
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Name: John G. Case Letter: G 6. 
A e: 40 years. Sex: Male. 
Admitted 4.4.39. Day of illness: 3rd. 
History: Two days ago the patient had a violent 
shivering fit, followed by a sharp, 
stabbing pain between the shoulders. 
Examination of Chest: Dullness of left upper lobe; 
breath sounds faint, with a few fine 
crepitations. 
Sputum: Type II. 
On 
Admission 
Treatment with M B 693 






104 p. min. 









White Blood. Count: On admission, 9,600 per c.cm. 
10.4.39, 9,000 " " 
X -ray: Pneumonic consolidation of upper part of left 
lung field. 
P+i. &: B. 693: Total dosage - 62 tablets - 31 `rms. 
Fall in temperature after 10 tablets. 
Discharged 18.4.39 after 15 days in hospital. 
Up on 10th day. 
142. 
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Name: Alexander B. Case Letter: 3 19. 
Age: 29 years. Sex: Male. 
Admitted 9.3.39. Day of illness: 5th. 
History: Complained of feeling unwell five days 
ago; this was followed by a pain in the 
right side of his chest, a`;gravated by 
breathing and coughing. 
Examination of Chest: Dullness of right lower lobe; 
absent breath sounds. 
Sputum: Type II. 
On 
Admission 
Treatment with K &- B 693 
After 24 hrs. After 48 hrs. 
Temperature 101 °F. 96.4 96 
Pulse 104 p. min. 86 60 
Respiration 48 p. min. 30 24 
Blood Pressure 100/60 
143. 
White Blood Count: On admission, 20,400 per c.cr. 
20.3.39, 13,400 " " 
X -ray: 13.3.39 - Consolidation of right lung field. 
22.3.39 - Almost complete resolution. 
M. & B. 693: Total dosage - 31 tablets - 15.5 crns . 
Fall in temperature 12 hours after admission, 
after 14 tablets. 
Complications: Inter lobar empyaema developing on 
15.3.39: drained. 
Discharged. 28.3.39 to Convalescent Home. 
Duration of stay in hospital: 20 days. 
144. 
















Case Letter: B 16. 
Age: 22 years. Sex: :ale. 
Admitted: 18.2.39. Day of illness: 2nd. 
History: Patient well till yesterday morning, when 
he wakened at 5 a.m. complaining- of pain 
all over his body; next he developed a 
severe pain in the left upper hart of his, 
chest. 
Examination of Chest: Dullness over left lower lobe 
posteriorly, reaching to anterior axil- 
lary line; bronchial breathing, with 
harsh crepitations. 








120 p. min. 
32 p. min. 
110/70 
Treatment with Y B 693 








White Blood Count: On admission, 27,000 per c.cm. 
X -ray: 2.3.39 - Negative. 
M. & B. 693: Total dosage - 28 tablets - 14 grms. 
Fall in temperature after 16 tablets, i.e. 
within 24 hours. 
Discharged 8.3.39 after 20 days in hospital. 
Up on 17th day. 
146. 
a 
Name: Joshua L. Case Letter: B 14. 
Age: 43 years. Sex: Male. 
Admitted 21.12.38. Day of illness: 4th. 
History: Feeling ill for four days. 
Examination of Chest: Lare area of consolidation 
at right base; marked general bronchitis. 
Sputum: Type II. 
On 
Admission 
Treatment with M & B 693 






134 p. min. 





White Blood Count: On admission 
M. & B. 693: Total dosage - 12 tablets - 6 grms. 
Summary: This patient died early the morning after 
admission, before the drug had time to 
become effective. He was very ill on 
admission, and also showed a marked 
general bronchitis. 
14cs . 
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Name: Charles H. Case Letter: K 11. 
Age: 16 years. Sex: Kale. 
Admitted 13.6.39. Day of illness: 2nd. 
History: Vomiting two days ago; on day before ad- 
mission, pain in the left iliac fossa. 
Examination of Chest: Diminished expansion of left 
base; dullness of left base: breath 
sounds diminished, tubular in character. 
Sputum: Type II. 
On 
Admission 
Treatment with P.I & B 693 
After 24 hrs. After 48 hrs. 
Temperature 100 °F. 97.4 97 
Pulse 114 p. min, 98 82 
Respiration 34 p. min. 32 24 
Blood Pressure 108/60 
149. 
White Blood Count: On admission, 17,500 per c .c_: . 
X -ray: Inflammatory consolidation of left base. 
M. & B. 693: Total dosage - 63 tablets - 31.5 gr_rris. 
Fall in temperature after 8 tablets, i.e. 
20 hours. 
Discharged 26.6.39 to Convalescent Home, after 14 days 
in hospital. 
on llt _ day. 
150. 






































Name: C. Case Letter: K 9. 
Age: 38 years. Sex: Male. 
Admitted 26.2.39. Day of illness: 2nd. 
History: Patient well till day before admission, 
when ìße had a sharp pain in the left side 
of the chest. A small amount of 
tenacious sputum. 
Examination of Chest: Limited movement on left side:. 
no impairment of percussion note. Vocal 
fremitus slightly increased over area the 
size of a five shilling piece round left 
nipple. Breath sounds harsh vesicular 
in that area, with coarse friction. 
Sputum: Type II. 
On 
Admission 
Treatment with M & B 693 
After 24 hrs. After 48 hrs. 
Temperature 102.6 °F. 99.6 97.6 
Pulse 110 p. min. 106 92 
Respiration 32 p. min. 30 25 
Blood Pressure 112/70 
151. 
White Blood Count: On admission, 15,200 per c.cm. 
23.2.39, 11,000 " " 
X -ray: Consolidation of left lung field. 
9.3.39 - Complete resolution. 
M. & B. 693: Total dosage - 46 tablets - 23 firms. 
Fall in temperature after 20 tablets, i.e. 
36 hours. 
Discharged 20.3.39 after 23 days in hospital. 
Up on 15th day. 
1[2. 
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Name: Samuel B. Case Letter: K 8. 
Acre : 63 years. Sex: I+íale . 
Admitted 27.12.38. Day of illness: 4th. 
History: Four days ago shivering and feeling ill. 
Pain developed in left side of chest that 
evening. 
Examination of Chest: No movement on left side of 
chest, with marked dullness at base, absent 
breath sounds and friction sounds over 
cardiac apex. 
Sputum: Type II. 
On 
Admission 
Treatment with TI & B 693 
After 24 Lrs. After 48 hrs. 
Temperature 98.2 °F. 99.4 98 
Pulse 108 p. min. 116 100 
Respiration 28 D. min. 36 28 
Blood Pressure 100/56 
153. 
White Blood Count: On admission, 9,500 per c.cm. 
31.12.38, 11,200 rr " 
2.1.39, 9,100 " " 
X -ray: Pneumonic consolidation of left lower lobe. 
Y. & B. 693: Total dosage - 58 tablets - 29 grins. 
Fall in temperature - irregular, never 
above 99.6 °F. 
Complication: Retention of urine. 
Death: 3.1.39. 
Summary: A thin, poorly nourished, toxic old man, 
with feeble pulse. No leucocytosis and, 
no response to ;,_ . B. 693. 
154. 
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Name: Arthur H. Case Letter: K 7. 
Age: 22 years. Sex: Male. 
Acirnitted 27.12.38. Day of illness: 2nd. 
History: Felt sick and shivery a week ago, and on da 
before admission had constant sharp Pain 
in right side of chest. 
Examination of Chest: Limitation of movement on nigh 
side; dullness over upper part of right 
side, anteriorly and posteriorly; high 
pitched bronchial breathing and a few fin 
crepitations. 
Sputum: Type II. 
On Treatment with M 6g3 
¡Admission Yter 24 hrs. After 4B _re 
Teffi,.erature 103.2®F. 
Pulse 82 p. '_ : , 
Respiration 40 p. . ._ : . 







White Blood Count: On admission, 6,200 per c.cm. 
31.12.38, 41,800 rr n 
5.1.39, 17,600 " " 
X -ray: 28.12.38 - Pneumonic consolidation of right 
upper lobe. 
M. & B. 693: Total dosage - 80 tablets - 40 grms. 
Fall in temperature after 18 tablets; rose 
again 24 hours later and continued for five 
days. 
Discharged on 10.1.39 to Convalescent Home. 
Duration of stay in hospital - 14 days. 
' ame : 
156. 
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Aae: 46 years. 
Admitted 10.1.39. 
Case Letter: K 6. 
Sex: Male. 
Day of illness: 3rd. 
History: Shivering attack six days before admission, 
and feeling unwell. Two days ago 
developed a bad gain in right side of 
chest. 
Exn- ination of Chest: Harsh vesicular breathing at 
right base, with crepitations. 








114 ,;+ . min 
26 w. min 
96/54 
Treatment wí th B 693 








White Blood Count: On admission, 11,000 per c.cm. 
16.1.39, 11,200 " " 
M. & B. 693: Total dosage - 50 tablets - 25 grms. 
Fall in temperature after 10 tablets. 
Discharged 18.1.39 to Convalescent Home after nine 
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George Case Letter: K 3. 
Age: 51 years. Sex: hale. 
Admitted 23.4.39. Day of illness: 1st. 
History: On day of admission patient developed a pain 
in the right side of the chest, with a 
cough which aggravated the pain. 
Examination of Chest: Limited movement of right side: 
dullness on percussion and harsh vesicular 
breathing in the right lower lobe. 
Sputum: Type II. 
On 
Admission 
Treatment with M B 693 






124 p. min. 









White Blood Count: On admission, 17,600 per c.cm. 
M. & B. 693: Total dosage - 60 tablets - 30 grins. 
Fall in temperature after 14 tablets, i.e. 
within 48 hours. 
Discharged 8.5.39 after 16 days in hospital. 
UD on 13th day. 
Name: 
160. 
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Mary B. Case Letter: 
Age: 13 years. 
Admitted 29.11.38. 
Sex: Female. 
Day of illness: 4th. 
History: Three days ago complained of a nagging pain 
in the right side; this became gradually 
worse, and hurt when she coughed. Cough 
was irritating and produced sputum tinged 
with dark blood. 
Examination of Chest: Diminished movement right side 
of chest; impaired percussion note of 
right upper lobe, with high bitched bron- 
chial breathing and increased vocal 
resonance, also many fine crepitations. 
Sputum: Type II. 
On 
Admission 
Treatment with ì,i B 693 






120 p. min. 









White Blood Count: On admission, 10,000 per c.cm. 
1.12.38, 12,400 " " 
5.12.38, 9,800 " " 
X -ray Pneumonic consolidation of right upper lobe. 
29.12.38 - Appearances normal. 
M. & B. 693: Total dosage - 34 tablets. 
Fall in temperature after 8 tablets, i.e. 24 
hours later. 
Discharged 3.12.38 after 34 days in hospital. 










Case Letter: 2. 
Sex: Female. 
Day of illness: 5th. 
History: Five days ago developed pains in the chest 
and shoulders, associated with a bad cough 
and copious sputum. 
Examination of Chest: Dullness at left base; tubular 
breath sounds and a few fine creaitations 
in this region. 
Sputum: Type II. 
On 
Admission 
Treatment with %.w B 693 
After 24 hrs. After 48 hrs . 
Temperature 101.2°F. 97.6 99.4 
Pulse 100 p.min. 8O ç6 
Respiration 24 p.min. 24 32 
Blood Pressure 132/70 
163. 
White Blood Count: On admission, 14,600 per c.cm. 
13.11.36, 9,600. 
X -ray: 16.11.38 - Inflammatory process fast resolv- 
ing. 
M. & B. 693: Total dosage - 35 tablets - 17.5 grins. 
Fall in temperature after 8 tablets, i.e. 
within 12 hours of admission. 
Complication: Temperature rose again to 101 °F. 60 
hours later, but fell within 8 hours and 
continued normal. 
Discharged on 24.11.38 to Convalescent Home after 18 
days in hospital. 
Up on 16th day. 
164. 
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Name: George ;."cL. 
Ade: 67 years. 
Admitted 2.11.38. 
Case Letter: A 2. 
Sex: Yale. 
Day of Illness: 4th. 
History: Patient had not been feeling well for four 
or five days. Three days before adis- 
sion he had a sharp pain in the right side 
of his chest, aggravated by coughing. 
Examination of Chest: Dullness of right upper lobe, 
with bronchial breathing and increased 
vocal fremitus and resonance. 
Sputum: Type III. 
On 
Admission 
Treatment with M & B 693 
After 24 hrs. After 48 hrs. 
Temperature 100.8 °F. 97.4 98 
Pulse 108 p. min. 88 88 
Respiration 28 p. min. 28 24 
Blood Pressure 140/90 
165. 
White Blood Count: On admission, 14,000 per c.cm. 
4.11.38. 16,000 " " 
X -ray: Consolidation of right upper lobe. 
M. & B. 693: Total dosage - 30 tablets - 15 grrnq. 
Fall in temperature after 8 tablets, i.e. 
within 12 hours. 
Complication: Delirium on second night after admis- 
sion, hecessitating transfer to special ward 
Discharged 21.11.38 after 20 days in hospital. 
III on 7th day. 
166. 
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Name: Charles C. Case Letter: A 3. 
Age: 56 years. Sex: Yale. 
Admitted 7.12.38. Day of illness: 4th. 
History: The patient has been troubled with a cough 
for three weeks before admission. Three 
days ago he had a shivering attack, followed 
by a sharp pain in the right side of the 
chest, aggravated by coughing and breath- 
ing. 
Examination of Chest: Dullness at right base, with 
diminished breath sounds, bronchial in 
character. 




Blood Pressure 150/90 1 
On 
Admission 
Treatment with M & B 693 
After 24 hrs.'After 48 hrs. 
1000F. 98 97.2 
124 p. min. 100 100 
32 p. min, 38 28 
167. 
White Flood Count: On admission, 20,800 per c.cm. 
27.12.39, 13,000 " " 
X -ray: Consolidation of right base. 
M. & B. 693: Total dosage - 42 tablets - 21 grms. 
Fall in temperature after 14 tablets, but 
rose a ̂.ain. 
Complication: Temperature rose again after 24 hours 
and continued for 14 days, off and on. 
Discharged 19.1.39 after 45 days in hospital. 
a on 37th day. 
16E. 
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Name: James D. Case Letter: A 6. 
Age: 62 years. Sex: Yale. 
Admitted 25.1.39. Day of illness: 3rd. 
History: Three days before admission patient felt 
very shivery and complained of pains all 
over body. On following day he develope4 
a very painful cough, with dark red sputum 
Examination of Chest: Impaired movement of right upper 
chest with dull percussion note. Vocal 
fremitus and resonance increased; low - 
pitched bronchial breathing. 
Sputum: Type III. 
On 
Admission 
Treatment with i: B 693 






92 p. min. 









White Blood Count: On admission, 11,600 per c.cm. 
X -ray: Consolidation of right upper lobe and a sug- 
gestion of fluid. 
9.2.39 - Inflammatory process has cleared 
considerably. 
M. & B. 693: Total dosage - 36 tablets - 18 grms. 
Fall in temperature after 14 tablets, i.e. 
after 24 hours. 
Discharged 15.2.39 after 21 days in hospital. 
UD on 13th day. 
17í;. 
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Name: John 









History: Five days ago pain in the chest, and 
shivering. 
Examination of Chest: Harsh vesicular breath sounds, 
coarse rhonchi and coarse friction 
sounds at left lower lobe. 
Sputum: Type III. 
On 
Admission 
Treatment with B 693 
After 24 hrs. After 4C hrs. 
Temperature 100.8°F. 99 97 
Pulse 160 p. min. 130 114 
Respiration 50 r. min. 32 32 
Blood Pressure 170/94 
171. 
White Blood Count: On admission, 9,600 per c.cm. 
4.5.39 9,000 f " 
X -ray: ? old inflammatory change in left lung. 
M. Ù 693: Total dose - 49 tablets - 24.5 firms. 
Fall in temperature after 20 tablets, i.e. 
in 24 hours. 
Discharged 27.5.39. after 26 days in hospital. 
172. 
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fame: Mrs Jean D. Case Letter: C 12. 
Age: 40 years. Sex: Female. 
Admitted 20.1.39. Day of illness: 5th. 
History: Pain in both sides of chest, with cough, for 
five days. On night before admission to 
hospital, pain localised to the left side. 
Examination of Chest: Dullness at both bases, with 
diminished vesicular breath sounds and 
fine crepitations. 
Sputum: Type III. 
On 
Admission 
Treatment with 1..r B 693 
After 24 hrs. After 48 hrs. 
Temperature 101°F. 98 97.2 
Pulse 110 p. min 104 84 
Respiration 32 n. min 36 22 
Blood Pressure 110/62 
173. 
White Blood Count: On admission, 11,000 per c.cm. 
28.1.39, 6,200. 
Y. & B. 693: Total c.osage - 22 tablets - 11 grins. 
Fall in temperature after 10 tablets. 
Discharged 8.2.39 after 19 days in hospital. 
L1. on 15th day. 
174 . 
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Name: Leonard R. 
Aoe: 48 years. 
Admitted 26.12.38. 
Case Letter: H 14. 
Sex: Yale. 
Day of illness: 4th. 
History: Been "of colour" for three weeks, with 
cold in head. On 23.12.38 developed 
pain in right side of chest, along with 
shivering attack. 
Examination of Chest: Diminished expansion of right 
side; dullness on percussion of right 
upper and lower lobes; tubular breathing. 
Sputum: Type III. 
On 
Admission 
Treatment with Y. B 693 
After 24 hrs. After 48 hrs. 
Temperature 99.4 °F. 
Pulse 104 p. min. 
Respiration 28 p. min. 








White Blood Count: On admission, 12,200 per c.cm. 
4.1.39, 8,500 it 
M. & B. 693: Total dosage - 54 tablets - 27 urns. 
Fall in temperature after 16 tablets, i.e. 
in 26 hours. 
Discharged 10.1.39 after J± days in hospital. 



















Name: Alexander _'cK. 
Age: 60 years. 
Case Letter: C 8. 
Sex: -ale. 
Admitted 26.3.39. Day of illness: 2nd. 
History: Had a cold a week ago. On 25.3.39 he had 
a shivering fit and pain in the right 
side of the chest. 
Examination of Chest: Diminished movement of right 
side; dullness and faint breath sounds. 
Sputum: Type III. 
On 
Admission 
Treatment with ?_ - B 693 
After 24 hrs. After 4E hrs. 
Temperature 100.8 °F. 98 97 
Pulse 96 per min. 96 74 
Respiration 20 per min. 24 22 
Blood Pressure 128/62 
177. 
White Blood. Count: On admission, 21,000 per c.cm. 
6.4.39, 8,400 ft 
X-ray: Consolidation of right lover lunT field. 
ï,. L. 693: Total dosage - 76 tablets - 38 firms. 
Fall in temperature after 20 tablets, i.e. 
in 24 hours. 
Discharged. 16.4.39 after 21 days in hospital. 
Up on 15th day. 
Name: 
178. 
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James C. 
Age: 26 years. 
Admitted 
History: 
Case Letter: H 16. 
Sex: Male. 
21.11.38. Day of illness: 4th. 
Headache, cold and shivering on 16.11.38. 
Next morning had a sharp pain in the 
right side of his chest. 
Examination of Chest: Diminished expansion right side 
of his chest; dullness of mid and lower 
lobes; breath sounds faint and friction 
over mid -lobe. 
Sputum: Type 12 - mainly streptococcal 
On 
Admission 






108 p. min. 
28 p. min. 
110/60 





White Blood Count: On admission, 7,800 per c.cm. 
1.12.38, 5,200 " " 
X -ray: 2.12.38 - Resolving pneumonia in mid -lobe. 
1V. B. 693: Total dosage - 20 tablets - 10 grms. 
Fall in temperature after 8 tablets, i.e. 
within 24 hours. 
Discharged 11.12.38 after 20 days in hospital. 
Up on 13th day. 
180. 
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Name: Charles R. 
Acre: 52 years. 
.a. 
Case Letter: C 3. 
sex: 
Admitted 28.10.38. Day of illness: 1st. 
History: On the morning of admission to hospital had 
a severe shivering attack followed by an I 
irritating cough and later a pain in his! 
left side. 
Examination of Chest: Impaired percussion note at 
left base, with diminished vesicular 
breath sounds and fine crepitations. 




Treatment with M °c B 693 
After 24 hrs.  After 48 hrs.I 
Temperature 102.6 °F. 97 98 
Pulse 128 p. min. 96 94 
Respiration 32 p. min. 32 2F 
Blood Pressure 72/52 
181. 
''íhite Blood Count: On admission, 18,000 per c . cm. 
9.11.38, 9,800 n n 
X -ray: 7.10.39 - Pneumonic consolidation of left lung 
field. 
N. cc B. 693: Total dosage - 31 tablets - 15.5 arms. 
Fall in temperature after 4 tablets. 
Toxic Symptoms: Sli Tht nausea; cyanosis. 
Complications: Carcinoma of penis - under treatment. 
Discharged 14.11.38 to Convalescent Home. 
Duration of stay in hospital: 17 says. 
















Name: Thady YcN. Case Letter: F 1. 
Ae: 19 years. Sex: Yale. 
Admitted 12.11.38. Day of illness: 3rd. 
History: Two days ago patient had headache, nausea 
and vomiting. He then developed pain 
in the left side of his chest. 
Examination of Chest: Dullness at left base: bronchQ- 
vesicular breath sounds with crepitation4 
at the height of inspiration. 
Sputum: Haemolytic streptococci. 
On 
Admission 
Treatment with M :5: B 693 
After 24 hrs. After 48 hrs. 
Temperature 101°F. 96.4 98.4 
Pulse 120 D. min. 90 74 
Respiration 24 p. min. 20 20 
Blood Pressure 140/84 
182. 
White Blood Count: On admission, 12,000 per c.cm. 
16.11.38, 8,200. n n 
ií. B. 693: Total dosage - 44 tablets - 22 gms. 
Fall in temperature after 14 tablets i.e. 
in 24 hours. 
Discharged on 28.11.38 to Convalescent Home after 17 
days in hospital. 
Up on 13th day. 
183. 
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Name: Jeanette McD. Case Letter: E 5. 
Age: 30 years. Sex: Female. 
Admitted 27.5.39. Day of illness: 2nd. 
History: Felt well till yesterday when patient had a, 
shivering fit and pain in the right side 
of chest. 
Examination of Chest: Dullness at right base: some 
friction and bronchial breath sounds just 
audible. 
Sputum: Non- haemolytic streptococci. 
On 
Admission 
Treatment with M B 693 






124 p. min. 









White Blood Count: On admission, 13,000 per c.cm. 
3.6.39, 8,000. " n 
M. ¿. B. 693: Total dosage - 32 tablets - 16 firms. 
Fall in temperature after 20 tablets, i.e. 
36 hours after admission. 
Discharged 22.6.39 after 26 days in hospital. 
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Mrs Jane S. Case Letter: E 10. 
Age: 26 years. Sex: Female. 
Admitted 14.2.39. Day of illness: 1st. 
History: Had influenza a week ago: this morning she 
developed a sharp pain in the region of 
the right breast, aggravated by breath- 
ing and coughing. 
Examination of Chest: Dullness ri &ht lower lobe: 
patches of bronchial breathing. 
Sputum: Non- haemolytic stretococci; some haemolytic 




Treatment with M B 693 






120 D. min. 









White Blood Count: On admission, 40,000 per c.cm. 
1.3.39, 12,000 r' TT 
X -ray: 7.3.39 - Chest not clear. 
Y. , , B. 693: Total dosage - 52 tablets - 26 grms. 
Fall in temperature - temperature did not 
fall till 25.2.39 and then tended to evening 
rise. 
Toxic Symptoms: Cyanosis. 
Discharged 3.3.39 to Convalescent Home. 
Duration of stay in Hospital: 13 days. 
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Name: Catherine T. Case Letter: D 7. 
Age: 18 years. Sex: Female. 
Admitted 8.11.38. Day of illness: 3rd. 
History: Two days ago felt cold and shivery, and 
later on the same day developed pain in 
chest and cough. 
Examination of chest: Dullness left base: vocal 
fremitus and resonance slightly increased; 
tubular breathing. 
Sputum: Type 1 and 16. 
On 
Admission 
Treatment with 1,1 & B 693 
After 24 hrs. After 48 hrs. 
Temperature 101 °F. 100 103.6 
Pulse 132 p. min. 130 126 
Respiration 32 p. min. 30 30 
Blood Pressure 120/70 
188. 
White Blood Count: On admission, 28, 100 per c.cm. 
21.11.38, 9,600. 
X -ray: Consolidation of left lower lobe. 
M. B. 693: Total dosage - 42 tablets - 21 firms. 
Fall in temperature after 42 tablets. 
Dischared 2.12.38 to Convalescent Home after 24 days 
in hospital. 
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Case Letter: E 14. 
Sex: 
Day of illness: 2nd. 
Felt cold and shivery two days before admisT 
sion; next morning had pains all over, 
with a sharp pain in the left side of the 
chest, worse on coughing and breathing. 
Examination of Chest: Dullness at left base. with 
Sputum: 
diminished breath sounds and friction rub 
Type 1 and 6. 
On 
Admission 
Treatment with M & B 693 






110 p. min. 









White Blood Count On admission, 11,006 per c.cm. 
14.11.38, 5,000. 
X -rav: 2:.11.38 - Complete resolution. 
M. &c B. 693: Total dosage - 30 tablets - 15 grins. 
Fall in temperature after 10 tablets. i.e. 
within 24 hours of treatment. 
Discharged 22.11.38 to Convalescent Home after 17 day 
in hospital. 
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Case Letter: .S 
Age. 17 years. Sex: ì;ïale . 
Admitted 9.3.39. Day of illness: 2nd. 
History: Patient has not felt well for past few days 
yesterday he had a severe pain in the 
chest, which was made worse by coughing 
and breathing. 
Examination of Chest: Dullness of left lower lobe; 
vocal fremitus and resonance increased; 
bronchial breathing in upper part of left 
lower lobe . 
Sputum: Types I and 18í4-. 
On 
Admission 
Treatment with M B 693 
After 24 hrs. After 48 hrs. 
Temperature 1030F. 101.8 96 
Pulse 108 p. min. 108 88 
Respiration 40 p. min. 28 28 
Blood Pressure 110/50 
192. 
White Blood Count: On admission, 12,400 per c.cm. 
14.3.39, 16,400 " 
X -ray: Consolidation present in the middle of left 
lung field. 
1. & B. 693: Total dosage - 60 tablets - 30 firms. 
Fall in temperature after 26 tablets, i.e. 
within 48 hours. 
Discharged 28.3.39 to Convalescent Home after 20 days 
in hospital. 
LE on 14th day. 
193. 
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Name: Arthur R. Case Letter: E 18. 
Age: 44 years. Sex: :ale. 
Admitted 11.4.39. Day of illness: 1st. 
History: Patient awoke with a severe pain in the 
right side of chest on morning of admis- 
sion; pain aggravated by breathing and 
coughing. 
Examination of Chest: Dullness of right lower lobe; 
bronchial breath sounds; vocal fremitus 
and vocal resonance increased. 
Sputum: Type 1-t +: Types 6, 20, and 22. 
On 
Admission 
Treatment with ,:. B 693 





102.8 °F. 100.4 
108 p. min. 100 






White Blóod Count: On admission, 7,200 per c.cm. 
21.4.39, 7,600 " " 
X -ray: 24.4.39 - No consolidation. 
M. & B. 693: Total dosage 84 tablets - 42 grms. 
Fall in temperature after 30 tablets. 
Toxic effects: Cyanosis. 
Complication: Temperature rose to 99.2 °F. on 6th day 
M. & B. given for a further two days; no 
further temperature. 
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Day of illness: 4th. 
History: Four days ago patient had headache. nausea 
and vomiting. He could not sleep and 
was hot and restless. He has had some 
pain in left side of chest. 
Examination of Chest: Dullness over left lower lobe; 
high pitched bronchial breathing, with 





Treatment with 3, & B 693 
After 24 hrs. After 48 hrs. 
Temperature 1OO.2°F. 98.8 97 
Pulse 98 p. min. 80 66 
Respiration 28 p. min. 24 22 
Blood Pressure 102/62 
196. 
Wilhite Blood Count: On admission, 12,000 per c.cm. 
M. & B. 693: Total dosage - 36 tablets - 18 grins. 
Fall in temperature after 10 tablets, i.e. 
within 24 hours. 
Discharged on 30.6.39 to Convalescent Home, after 10 
days in hospital. 
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Name: Robert B. Case Letter: C 7. 
Age: 43 years. Sex: ì- ale . 
Admitted 3.4.39. Day of illness: 2nd. 
History: On Saturday (1.4.39) the patient had a 
shivering fit and the next day he had a 
sharp pain in the ri;-ht side of his chest 
Examination of Chest: Restricted movement of right 
side; dullness over the right lower lobe; 





Treatment with M & B 693 






108 p. min. 









l'Jhite Blood Count: On admission, 14,500 per c.cm. 
6.4.39, 8,800. " " 
X -ray: 4.4.39 - Consolidation of right base. 
18.4.39 - Condition unchanged. 
. ii. 693: Total dosage - 65 tablets - 32.5 Lrms. 
Fall in temperature after 22 tablets. 
Complications: Temperature rose sli7htly on the 9th 
and 12th days. On the 15th day it reached 
104°F. and ç,: B. 693 was again started - in 
all 41 tablets - and the temuerature fell 
after 35 tablets. Temperature was due to 
marked axillary adenitis. 
Discharged on 7.4.39 after 34 days in h osoital. 
L ? on 28th day. 
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Name: Thomas NIGH. 
Age: 14 years. 
Admitted 9.2.39. 
Case Letter: B 17. 
Sex: ale. 
Day of illness: 4th. 
History: Cough and pain in the right side of the 
chest for three days. 
Examination of Chest: Dullness of right lower lobe 
and increased vocal fremitus; harsh 





Treatment with h B 693 
After 24 hrs. After 48 hrs. 
Temperature 102°F. 99 101.4 
Pulse 126 p. min. 110 120 
Respiration 40 D. min. 30 35 
Blood Pressure 98/62 
200. 
White Blood Count: On admission, 18,333 per c.cm. 
16.2.39, 9,130. " rr 
X -ray: 13.2.39 - Consolidation of right lower lobe. 
2.3.39 - Chest now almost clear. 
Y. c. B. 693: Total dosage - 13 tablets - 6.5 ;rms. 
Fall in temperature after 13 tablets, i.e. 
7th day of illness. 
Discharged 7.3.39 after 26 days in hospital. 
MD on 16th day. 
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Name: Magnus R. Case Letter: H 13. 
Age: 19 years. Sex: >:ale . 
Admitted 7.1.39. Day of illness: 4th. 
History: On 4.1.39 patient developed rain in right 
side of chest, with headache, nausea and 
vomiting. 
Examination of Chest: Diminished expansion of right 
side of chest; dullness of the right rid 
and lower lobes; absent breath sounds in 




Treatment with " B 693 






110 p. min, 









White Blood Count: On admission. 10,330 per c.cm. 
17.1.39, 6,300 " " 
X -ray: Pneumonic consolidation of lower two- thirds of 
right lung field. 
6.2.39 - clear. 
Y. & B. 693: Total dosage - 39 tablets - 19.5 arms. 
Fall in temperature after 10 tablets. 
Discharged on 31.1.39 to Convalescent Home after 24 
days in hospital. 
UP on 15th day. 
203. 
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N ame : Jacob I';ï. 
Age: 15 years. 
Admitted 6.3.39. 
Case Letter: H 11. 
Sex: Male. 
Day of illness: 3rd. 
History: Well till evening of 4.3.39, when he felt 
cold and shivery, and had a pain in the 
right side of his chest. 
Examination of Chest: Diminished movement on right 
side; dullness of right middle and lower 




Treatment with P.'. B 693 
After 24 hrs. After 48 hrs.; 
Temperature 102.2 °F. 97.8 98 
Pulse 110 D. min. 98 81 
Respiration 42 p. min. 40 30 
Blood Pressure 104/70 
204. 
White Blood Count: On admission, 20,200 per c.cm. 
9.3.39, 19,400 " " 
Y. < B. 693: Total dose - 7S tablets - 39 firms. 
Fall in temperature in 12 hours, i.e. after 
10 tablets. 
Discharged on 27.3.39 after 21 days stay in hospital. 
a on 11th day. 
N ame : 
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Joseph P. Case Letter: C 6. 
Age: 61 years. Sex: 
Admitted 11.1.39. Day of illness: 2nd. 
History: Pain behind the right shoulder for two days 
cough for four months; swelling in the 
throat being treated by X -ray. 
Examination of Chest: Diminished movement and dullne 
at right base; breath sounds obscured by 
pleural friction. 
Sputum: No organisms. 
On 
Admission 
Treatment with !' B 693 
After 24 hrs. After 48 hrs. 
Temperature 102.60F. 98.4 97.2 
Pulse 114 p. min. 116 100 
Respiration 26 n. min. 18 24 
Blood Pressure 12886 
s 
206. 
White flood Count: On admission, 15,800 per c . cm. 
13.1.39, 11,800 " " 
15.1.39, 16,600 " " 
X-ray: Onacity of the lower part of the right lung 
field. 
M. & B. 693: Total dosage - 24 tablets - 12 grins. 
Telrperature fell after 12 tablets, i.e. 16 
hours after admission. 
Complications: Carcinoma of the pharynx with exten- 
sive secondaries of the liver and associate_ 
lymph plands. 
Death 17.1.39. 
Post -mortem: Carcinoma of pharynx: secondaries of 
liver and F4-lands. Patchy consolidation of 
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fame: i rs Ellen W. 
Age: 56 years. 
Admitted 3.1.39. 
Case Letter: D 10. 
Sex: Female. 
Day of illness: 1st. 
History: Patient had not felt well for one week be- 
fore admission. She had a cold, accom- 
panied by some cough. On day of admis- 
sion she woke with pain in risht side and 
shivering_ attack. 
Examination of Chest: Dullness on percussion at righ 
base; hoarse vesicular breathing and in- 




Treatment with i1í & B 693 
Temperature 103 °F. 
Pulse 100 p. min. 
Respiration 32 p. min. 
Blood Pressure 104/68 





White Blood Count: On admission. 14,000 Too' c.em. 
. 693: Total dosage, 32 tablets - 10 o'ms 
Fall of temperature after 12 t blf is , 
within 24 hours. 
Discharged on 21.1.39, after ld days in hospital. 
rn on 15th day. 
Name: 
209. 
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Case Letter: E 4. 
Sex: 
Day of illness: 2nd. 
History: Had a cold for about a reek; pain in right 
side of chest for one day, worse on cough- 
ing. 
Exa::ination of Chest: Impaired percussion note; 










104 p. min 
28 p. min 
8042 
Treatment with D B 693 








White Blood Count: On admission, 8,403 per c.cm. 
6.6.39, 8,030 " " 
X-ray: 12.6.39 - No consolidation; sorse increased 
density of right base. 
V. cc B. 693: Total dosage - 26 tablets - 13 grins. 
Fall in temperature after 10 tablets. 
Dischared on 15.6.39 to Convalescent Home after 13 
days in hospital. 
Up on 10th day. 
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ULM MILD 7r at" IfUIM.,cm 
r ame : Andrew G. 
Ar e : 46 years. 
Admitted 22.4.39. 
Case Letter: E 7. 
Sex: Male. 
Day of illness: 2nd. 
History: Pain in chest for one day; had a shivering 
fit on day before admission, and then 
later had pain in left side of chest. 
Examination of Chest: Dullness of left lower lobe, 




Treatment with I'. 1 B 693 
After 24 hrs. After 48 hrs 
Temperature 103 °F . 100 97 
Pulse 120 D. min. 120 84 
Respiration 28 p. min. 30 24 
Blood Pressure 150/110 
212. 
White Blood Count: On admission, 7,500 per c.cm. 
27.4.39, 23,600 " " 
2.5.39, 11,200 " " 
M. & B. 693: Total dosage - 32 tablets - 16 grms. 
Fall in temperature after 18 tablets. 
Complications: Temperature rose again on 25.4.39, 
i.e. 5th day of illness; 28 tablets of 
M. & B. 693 were given, with no effect, and 
the temperature fell after five days. 
Discharged on 18.5.39 after 26 days in hospital. 
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Robert E. Case Number: E 13. 
12 years. Sex: :.:ale. 
31.12.38. Day of illness: 3rd. 
Shivering and vomiting three days ago, 
followed by pain in left side of chest. 
Examination of Chest: Dullness of left lower lobe; 






Food. : ressure 
On 
Admission 
Treatment with Y rf B 693 
After 24 hrs . fter 4% hrs. 
100.2°F. 
98 D. min. 








White Blood Count: On admission, 17,000 per c.cm. 
4.1.39, 7,200 '" " 
Y. B. 693: Total dosage - 32 tablets - 16 gyms. 
Fall in temperature after 16 tablets. 
Toxic Symptoms: Vomiting on 4th day of treatment. 
Discharged on 13.1.39 after 14 days in hospital. 
215. 
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Name: T..rs nary L. Case Number: A 11. 
Abe: 66 years. Sex: Female. 
Admitted 1.2.39. Day of illness: 3rd. 
History: Had been in bed for three weeks, due to poor 
health; then, two days before admission, 
was troubled by pain in the left side of 
the chest, which was aggravated by cough - 
ing. 
Examination of Chest: Impaired movement on left side, 
with dullness at base; bronchial breath- 




Treatment with ï` L,c B 693 
After 24 hrs. After 48 hrs. 
Temperature 99.8 °F. 98.4 98.4 
Pulse 120 p. min. 92 80 
Respiration 30 p. min. 24 24 
Blood Pressure 11065 
216. 
dhite Blood Count: On ad.fnission . 14,000 per c . cm. 
it . B. 693: Total dosage - 28 tablets. 
Fall in temperature after ].0 tablets. 
Discharged on 22.2.39 after 21 days in hospital. 
Up on 16th day. 
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Name: Lindsay R. Case Letter: Iú 3. 
Age: 81 years. Sex: I,Iale . 
Admitted 17.2.39. Lay of illness: 1st. 
History: Not so well for some time past; had to o 
shop-Ana for groceries - collapsed and 
brought to hospital. 
Exaliiination of Chest: Increased dullness of left side 
of chest; fine crepitations. 
Sputum: Not typed. 
On 
Admission 
Treatment with I.: k. B 693 






104 p. min. 









White Blood Count: On admission, 7,400 per c.cm. 
21.2.39, 9,600 " 
M. &. E. 693: Total dosage - 19 tablets - 9.5 gm. 
Fall in temperature after 8 tablets, i.e. 
9 hours after administration. 
Complication: Admitted as a case of auricular fibril 
lation with right bundle- branch block; 
myocardial degeneration and coronary infarct 
Pneumonia did not set in till third day in 
hospital, and was re_arded as terminal. 
Discharged 27.3.39 to Hospital for Chronic Illnesses, 
after 38 days in hospital. 
Up on 7th day. 
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Name: Robert D. Case Letter: A 5. 
Age: 35 years. Sex: Male. 
Admitted 25.1.39. Day of illness: 2nd. 
History: Patient left hospital after operation for 
inguinal hernia five days ago. Yesterda 
he had an attack of shivering, followed b 
a sharp pain in the right side of the 
chest. 
Examination of Chest: Diminished movement and im- 
paired note at right base; bronchial 
breathing. 
Sputum: No reaction to any type. 
On 
Admission 
Treatment with M & B 693 
After 24 hrs . After 48 hrs. 
Temperature 100.80F. 99.4 99 
Pulse 116 p. min. 104 96 
Respiration 30 p. min. 30 30 
Blood Pressure 125/70 
220. 
White Blood Count: On admission, 14,200 per c.cm. 
M. & B. 693: Total dosage - 30 tablets - 15 grins. 
Fall in temperature after 24 tablets - slow 
response. 
Discharged 18.2.39 after 24 days in hospital. 
Up on 13th day. 
221. 
L I S C U S S I O I,T . 
It is at this stage that it becomes necessary to 
marshall the facts which will help us to give an 
answer to the various questions which we have set our- 
selves to answer. 
Eighty -five cases of Lobar ?r_eumonia have been 
treated with 2- sulphanilyl- aminopyridine, or 
693, and the important features of each have been set 
out in the previous section. Tat inforration. then, 
has been acquired in treating these cases? Has the 
discovery of T.i. B. 693 brou`ht us nearer to a solu- 
tion of the - problem of the treatment of Pneumonia? 
At the outset I realise that the number of cases 
treated is comparatively small and that, in consequen e, 
no final opinion can to given from their survey. It 
is possible, however, to draw certain conclusions andl 
these, with the results of other observers, may serve 
to add something to the assessment of this drug Y. 
B. 693. 
;:'hat effect, then, does treatment with B. 
693 have on the course of a case of pneumonia? Has 
it any striking action on the disease? To this 
question the answer is undoubtedly lyest. In the 
222. 
majority of cases there is a dramatic effect within a 
short period of the initial administration of the 
drug. In an interval varying from twenty -four to 
thirty -six hours, and in most cases within the twenty - 
four hours after giving Y. -J.. E. 693, the temperature 
falls abruptly and sharply to normal. This fall in 
the temperature is very impressive, but certain ques- 
tions immediately arise to the .rind. P,?ight not tbis 
be due to a simple antipyretic action exerted by the 
drug and, as such, perhaps not calculated to have a 
favourable influence on the outcome of the disease? 
That this response to Y. w E. 693 is something differ- 
ent from a means of lowering the temperature is sug- 
gested by two factors. Firstly, in most cases this 
fall in temperature is maintained from the moment it 
starts and, although minor rises of temperature, of 
fractions of a degree, may occur, they do not appear 
to be of great significance. In the second place, 
nothing could be more impressive than the change whic 
takes place in the patient's appearance. behaviour an 
general well -being. From a being gravely ill, 
obviously ravished by a powerful toxin, grievously 
distressed and in nain, he is transformed, as if by al 
miracle, to a state of relative tranquility, peace ans. 
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freedom from pain. When M. B. 693 was first used, 
I can recall several Patients whose appearance was 
such as to su-,-,est that a fatal outcome was iimuine t 
in a matter of hours, and in whom this striking ch.a.n ; 
was brou_ht about. Those two factors, then, and in 
particular the latter constitute evidence which is no 
unconvincing that the action of , 693 is more 
than that of a simple antipyretic. 
The sudden fall in temperature leads to yet 
another question. Could this be nothing more than 
the crisis which normally occurs in the majority of 
cases of pneumonia_ about the seventh day of the 
disease? Admittedly in those cases which did not 
come under treatment with L. 6G3 till the fifth 
or sixth day of the illness, such an orinion might reI1 
be justified. That this is not the case is s?a °este 
by the fact that a similar e'-fect is shown in cases 
treated with t[e drug within h:e first trtenty -four 
hours of the onset of the disease, and also in canes 
treated on the second, third and fourth days 
illness. The sup ,gestion becomes a conviction when 
case after case, with very fern exceptions, reajlorì 
by a fall In temperature acccrrr a 
,,he better i.. the - 
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condition. Furthermore, in the greater proportion 
of cases this improvement is maintained and the 
patient strides rapidly along the road to recovery. 
It thus becomes evident that in B. 693 we 
have a drug capable of exerting an influence directly 
on the purveyor of the toxin causi n` the illness - th e 
pneumococcus. Regarding the mode of action of . 
B. 693, information has been detailed i_ a -1-'1=7:12 _.s 
section (page 21). 
Table 1 below shows the number of cases 
a given day of illness. - 
Table 1. Table la. 
on 





After 4th Day 
In this series of eighty -five cases of all 
ages (see Table la) treated with ï;.. Li. 695. eases. 
or 74.1 showed this response of fall in temperature 
(Evans and Gais ford , 60?Iji 4E hours) along; with 
general improvement, within twenty -four hours . Four 
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cases (4.7) died. In the remaining thirteen, or 
15.5:, the response was variable. Five cases (5.9`) 
did not respond till 4E -72 hours. In some of these 
cases the temperature fell within twenty-four hours, 
only to rise again on a subsequent day. In others 
there was no satisfactory response. These cases wil 
be examined in more detail at a later stage. 
lWhitby,9 in his experimental work on nneummococca 
infections in mice. found that . & E. 693 gave pro- 
tection against Types I, II and I+_I and in Croup `T 
against Types V, VII and VIII. It will now be of 
interest to observe what effect 693 exerts on 
the different Types of Pneumococcus as they occur in 
man. It may be that here we shall find a reason for 
the variable response in 15.3`_ of the cases. Could 
it be that a particular type of Pneumococcus is 
resistant to the action of the drug? The question 
also arises as to whether or not E. 693 has any 
effect on pneumonia caused by organisms other than the 
nneumococcus, e._. the streptococcus. 
The incidence of the various types of pneu_mococci 
and other organisms causing pneumonia in this series 












Other Mixed Organisms 
Streptococci 
Untyped 









The types of Group IV or_anisms which occurred 
are shown in Table 3. 
Table 3. 






















In pneumonia due to Type I infection there were 
seven c ases in this series. In five of those there 
was the d_ra Tati c fall in tennerature , along with 
general i_nprove.nent . in twenty -four hours. The 
remaining two cases, K 2 and A 1, did not show this 
response till seventy -two :_-ours after admission. 
Table 4 shows the day of illness on which 
patients suffering from Type I pneumococcal infection 
were admitted to hospital. 
Table 4. 
Type I 





After 4th day 





Thirty -three of the eighty -five cases which came 
under observation were due to Type II nneumococcus. 
It is noteworthy in passing that in this area of 
South East Scotland the largest proportion of the 
cases was due to this type of pneumococcus. The 
day of illness on which patients were admitted is 















Jf these thirty -three cases, three died and of 
the remainder only three failed to respond by the 
drop in temperature after treatment with zc B. 693. 
In those three cases there was an initial fall in 
temperature. .;¡.-;Ti but this was not maintained. In 
case K 9 there was a rise of temperature along with a 
recurrence of symptoms after twenty -four hours and 
this was not affected by further administration of 
M. B. 693, the temperature falling by crisis on the 
fifth day after admission. In case A 8 the patient 
responded well to 0: B. 693, the temperature, pulse 
and respiration rate falling to normal within twenty- 
four hours. Four days later. however, there was a 
recrudescence of symptoms and suns of pneumonic 
consolidation became evident on the opposite side of 
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the chest in the right lower lobe. Administration 
of ìr;. & B. 693 after this occurrence produced no 
effect. After a favourable response in case D 1. 
temperature rose again on the sixth day and fell 
twenty -four hours later and ctinued normal. 
Seven cases of Type III pneumococcal infection 
occurred in the series. The day of their admission 















Except one case. A 6, in which the temperature 
did not fall till an interval of forty -eight hours has 
passed from the initial administration of the drug, 
all the others responded in twenty -four hours. In 
one case, however, A 3, there was a recurrence of 
temperature which persisted for fourteen days in Spit 
of continued treatment with Y. _ B. 693. 
The series contained sixteen cases of infections, 
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of the Group IV class, the various members of this 
class which occurred having already been shown in 
Table 2. The number of cases admitted on the variou 













In eleven of the cases the usual _response to the 
drug was obtained. Two cases, G 9 and G 2, showed 
an irregular rise of temperature after the initial 
fall. In one patient, A 10, the drug had to be 
stopped and the temperature fell by lysis on the ninth 
day. Another, K 10, showed no response, the tempera- 
ture falling on the eighth day, while in case L 2 the 
temperature rose twenty -four hours after the initial 
fall but subsided after a further forty -eight hours. 
Pneumonia due to more than one organism occurred¡ 
in four cases; the organisms were pneumococci as 




Types of Pneumococcus Case 2:o . 
Types 1, 16 L 7 
Types 1, 18 E 14 
Types 1, 6 B 15 
Types 1, 6, 20, 22 B 12 
Of the mixed pneumococcal infections on17 one 
responded in twenty -four hours to treatment with 
.:. & B. 693. Two responded in forty -eight hours ar_ 
one in seventy -two hours. 
Four cases were due to the streptococcus and 
those the temperature fell in twenty -four hours and 
remained normal. A fifth showed a mixture 
tic and non -haemolytic streptococci. staphylococci and 
micrococcus catarrhalis and failed to res cn to 
B. 693. 
There were thirteen cases in which the causal 
organism was not determined. In only one of these. 
E 7, was there any subsequent rise in temperature after 
the initial fall. A 5 did not resrond till seventy - 
two hours later and then remained normal. 
In these preceding pages, then, we have suit ar- 
ised how the various types of pneumococci responded 
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to treatment with 2.: B. 693. The question now 
arises why certain cases failed to respond. Can we 
throw any light on this matter? In the first place 
we must ask ourselves if in any of the cases which 
failed to respond in the normal manner there was in- 
adequate dosa e. In cases 'r" 2 and A 7, both Tyce I, 
which did not respond till seventy -two hours after th 
beginning of treatment, the usual dosaJ.e of the drug 
was not given till this time had elapsed. Vomiting 
occurred in cases 10 (Group IV and A 10 (Croup IV) 
and it is reasonable to assume that because of this 
the drug was not absorbed in sufficient quantity into 
the blood stream. In cases A 3 (Type III), D i and 
K 9 (Type II) and E 9 (untyped) the standard dose which 
in the majority of cases produced an adequate blood 
concentration was given but, in spite of showing an 
initial response, this was not maintained, temperature 
recurring 
that even 
unable to maintain a sufficient blood concentration 
either through failure of absorption or too rapid 
excretion? The dosage in these cases was, A 3 - 21 
grms., D 1 - 31 grins . , K 9 - 40 gyms . , E 9 - 16 grms. 
Another explanation might be that a recrudescence of 
at a later stage in all cases. Could it be 
with the normal dose those individuals were 
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the pneumonia process had occurred. This was cer- 
tainly the case in case A 8 (Type TT), in which si7ns 
of consolidation occurred in the other side of the 
chest. A striking; feature about this new pneuocccci 
process is that :, . B. 693 exerted no influence on 
it in spite of larce dosage. Re`,ardin J this failure 
of b. 6-23 to influence such a recrudescence, it 
is interestin, to recall the obser-rations of Teilin 
and Oliver2 who found that after treatment with 
B. 693 the nneumococcus isolated from the sputum wPs 
atypical and did not - cive the agglutination reaction 
with the type specific serum as it had _na1-7,7 
done. This raises the question as to whether in 
this case A 8 and in those others in which there was 
a recrudescence of symptoms after the initial fall. 
the rise in temperature might not be due to a low - 
Frade infection with a changed type of oneumococcus. 
That such a changed organism r i:_ht be resistant to 
ì,:. L. 693 is sugeested by Whitby (Eradshaw Lecture) 
who drew attention to the occurrence of resistant 
strains of oranisms. ie instanced cure in some 
acute cases of : onorrhoea, while in others the occur- 
rence of r recrudescence of infection showed resistance 
to the compound. It may be asked if such a resistant 
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strain could develop in the short space of twenty -four 
hours to six days and, in ans-Ner to this, it may be 
said that Telling; and Oliver23 found these changed 
pneumococci after administration of 3 g .rms . L.. B. 
693. 
In two cases, G 9 and G 2 (Group IV) the recur- 
rence of temperature might be said to be due to the 
presence of fluid at the luna base. After removal 
of this, the symptoms subsided. 
Only one case of mixed infection responded to 
Y. B. 693. In one. D 7. there was complete lack 
of response in spite of a dosage of 21 grms. In the 
remaining two cases, B 15 and B le, a dosage of 13 
firms. and 15 firms. respectively was necessary before 
the temperature fell to normal. It is perhaps not 
unreasonable to suppose that these cases are more 
resistant to treatment and that their response to 
I. ú. B. 693 will be variable. 
In spite of the fact that the response of certaii 
cases in this series has been variable: it seems that 
the only :-group in which we must say the action of 
N. B. 693 is doubtful is that in which mixed infec- 
tions occur. I say this because, out of four cases, 
in one the drug failed completely and in two others a 
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lar er dosage was required. In all other types the 
majority of cases responded and in those which did 
not there had been the possibility of too little of 
the drug, through vomiting, entering the blood stream 
or, in other cases, recrudescence, possibly due to a 
resistant or changed organism. It seems certain, 
then, that when a diagnosis of pneumonia is made on 
clinical grounds. ti B. 693 should be emoloyed and, 
if this is done, there is every reason to expect a 
favourable response. The :procedure of typing sputi.m 
is thus unnecessary. 
Perhaps one of the first questions asked when a 
new preparation appears for the treatment of a diseas 
is what effect does it have on the Yr_ortality. Such 
a question is natural in the case of all diseases but 
in none more so than pneumonia, for very often it is 
responsible for a large number of deaths in people 
who are in the prime of life. 
Of the eighty -five cases, at no matter what stag 
of the disease L. B. 693 was given, only four died, 
giving a mortality of 4.7 ¡. In the absence of a 
control series, a strict comparison cannot be made 
but a fi;- °ure such as this in a group of cases of 
different types of lobar pneumonia is far below any 
recorded with other methods of treatment, even ta':ing 
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into account the well - known variation in the severity) 
of the disease. 
Table 9, below, shows the mortality from all 
cases of lobar pneumonia admitted to the Royal Infir- 













i."ortality 23.28°: 2e.4- 49.2- 39.22 
In seven cases of Type I there were no deaths. 
0 
Out of sixteen cases of this type Graham et al26 had 
no deaths, and Flippin et alt' in twenty -six cases 
report similar findings. Pepper al, on the 
other hand, in one hundred and four cases of Type I 
pneumonia had a mortality of 5.8_. 
Type II pneumococcus was responsible for three of 
the four deaths in this series - Cases A 7, 3 14, K 8. 
All of these patients were over forty years of age. 
Case A 7 responded well to the drug, the temperature 
falling within twenty -four hours. The temperature 
remained normal but on the fifth day the patient 
died and at post -mortem examination, double pneumonia 
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hypertrophy and dilatation of the heart along with an 
old -standing pericarditis, were found. Case B 14 ha4t 
marked pleural bronchitis and died shortly after ad- 
mission. Case K 8 was an old man whose temperature 
was never high but in whom there were undeniable signs 
of pulmonary consolidation con_fir_ned by X -ray examina- 
tion. Large doses of f. B. 693 failed to prevent 
the fatal outcome. 
These three deaths constitute a mortality of 9.6T 
from this type. Pepper et al54 had thirty cases of 
Type II infection in their series of four hundred 
cases, with a mortality of 6.7 No deaths occurred 
in the four cases occurring in the series reported by 
0 
Graham et al2 
In Pneumonia caused by Type III, of which there 
were seven cases, all survived. This type of pneumo- 
coccus is well known for the frequency with which it 
attacks people over forty years old and for its all t 
frequently fatal outcome. Even in a small number o 
cases the failure of Type III pneumococcus to cause ally 
deaths is encouraging. In four hundred cases, Pepper et 
al`4 had sixty -three cases, with a mortality of 16.4 %. 
No deaths occurred in Pneumonia due to Group IV 
mixed or streptococcal infections. The remaining 
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death was case L 6, in whose sputum no pneumococci were 
found. This case was complicated by the presence of, 
carcinoma of the oesophagus and it is of no little 
interest to note that after treatment with M. B. 693 
his temperature returned to normal. Several days 
later, however, he succumbed to the original disease.' 
This very striking reduction in the mortality 
from pneumonia with the use of . : E. 693 is extreme- 
ly Stratifying and in itself is a strong argument in 
favour of the use of the drug. 
With a drug such as 3. 693 it is important 
that we should reach some conclusion about dosage and 
as to the best method of employing the preparation. 
From animal experiments with B. 693 it soon be- 
came evident that with a given dosage certain varia- 
tions of the concentration of the drug in the blood 
stream occurred. Baines and Wien18, Bliss and 
Long55 and Hobson and WacQuaide21 showed that in 
man such was also the case. The variations in 
blood concentration experienced are thought to 
depend on such factors as the rate of absorption, 
rate of excretion and rate of acetylation of the 
drug, (Stokinger19). That the general state 
of health may also play a part is postulated by 
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Hobson and NcQuade21. In view of this, then, one 
wondered if it might be necessary to estimate the 
blood concentration of the drug by elaborate labora- 
tory means throughout a course of treatment. Should 
this prove to be the case, the scope of the drug must 
then be lirited to places in which such investigation 
could be made. 
Flippin et a127 were able to sho-: , however, that 
a concentration of 1 to 2.8 mgm. per 100 cc.s was as 
effective as a concentration of 1J mgms. or more per 
100 cc.s. The important practical consideration, 
then, was to know if a stated dosage would, in a suf- 
ficiently large number of cases, produce a concentra- 
tion in the blood stream which would be adequate to 
overcome the pneumococcus. 
Evans and Gaisford11 in their original series 
gave one tablet, or 0.5 gm. four- hourly for the first 
three or four days, followed by one tablet twice dail 
for two to three days, giving in all a total of 12 gm 
In the absence of severe toxic symptoms they later 
suggested that the dose should be increased, to 2 gms. 
- four tablets on admission followed by 1 gi. - two 
tablets, four- hourly for seventy -two hours, making a 
total of 25 gms. - fifty tablets. In this series, 
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as stated before, the practice has been to give a 
uniform dose in most cases in the first twenty -four 
hours, as follows:- Four tablets, 2 gms., on admis- 
sion, followed by a similar dose four hours later and 
then 1 gm., two tablets, four -hourly for four doses. 
After this the subsequent dosage was varied and will 
be dealt with later. By this means a dosage of 
7 -8 gms., fourteen to sixteen tablets, was given in 
the first twenty -four hours. In a large proportion 
of cases this dosage was sufficient to produce a re- 
sponse as shown by fall in temperature and general 
improvement in twenty -four to thirty -six hours. It 
is thus reasonable to deduce that this dosage is suf- 
ficient to produce a concentration in the blood ade- 
quate to overcome the oneumococcus. That this dosag 
is necessary is borne out by the fact that in cases 
where this amount was given over a longer period, no 
response occurred till it had been given in full. 
This point can best be illustrated by the follow 
n7 cases, viz:- Case C 4, 14 tablets or 7 gms Y. Pr, 
. 693 were given over a period of thirty -two hours 
and then the response was obtained. In case K 2, 
14 tablets or 7 gms. R. a: B. 693 were given in se vent 
t hours and in case A 1, 1F, tablet- or 74 gms. in 
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the same period and it was only at the end of this 
time that the temperature fell to normal. 
This point is illustrated in 
Table 10. 
Table 10 below. 
Case No. C 4 K 2 A 1 
Dose 3. 693 7 gms. 7 gras. 7 grrls . 
Time in which given 32 hrs. 72 hrs. 72 hrs. 
Time taken for response 32 hrs. 72 hrs. 72 hrs. 
It thus becomes obvious that the sooner adequate 
dosage is administered the sooner a favourable re- 
sponse may be expected. 
With regard to the total dose of . 693, 
this was varied within certain limits throughout the 
series. The results are drawn up in tabular form 
in Tables 11 (a) and (b), Table 12, Table 13 (a) and 
(b), Table 14 and Tables 15 (a) and (b). 
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Table 11 (a). 
M. & B. Total Dose - 18 -26 Tablets. 
Case No. K 5 C 9 M 4 C 8 C 11 %: 1 O 12 H 16 B 17 
Response + + + + + + + + + 
Remarks Nil Vomit Vomit Nausea Vomit Aet 13 Nil Nil Aet 14 
Table 11 (b) . 
18 -26 Tablets. 
Case No. C6 E4 M3 K 1 F 6 B 16 B 12 
Response + + + + + + + 
Remarks Death ¡ Nil Aet 81 Nil Nil Nil Pregnant 
Table 12. 
27 -30 Tablets. 
Case 'C 
T 
4 H 12 
T 
A 10 C5 A 7 4 A 11 E 18 A 5 A 2 D 2 D 9 
Response + + - + + + + + + + + + 
Remarks Nil Aet 15 Vomite Aet 14 
Nil Nil Nil Nil 72 hrs.Nil Nil 
Table 13 (ai. 
31 -36 Tablets. 
Case No. F 2 E 12 E 8 D 6 D 4 C 7 B 19 M2' D5 I D 8 
Response + + + + + + + + + +_, 






Table 13 (b). 
31 -36 Tablets. 
Case No. D 3 A 6 C 3 E 5 G 1 A 9 A 8 E 13 E7 ID 10 E 11 
Response + + + + + + + + + + _ 









37 -50 Tablets. 
Case No . L 2 
t 
L 3 L 1 L 4 E 6 K 9 H 13 D 7 F l A 3 B 13 K 2 G 3' 













Table 15 (a) . 







K 11 H10 Ill 15 D1 K4 K10 G2 
Response + + 
+ 






















Table 15 (b). 
50 Tablets or more. 






Temp. No Re- 
6th sponse 
i day 
In the cases in which the total dosage did not 
exceed 26 tablets, or 13 grms., there was usually some 
reason such as vomiting for stopping the drug at this 
stage. It is significant to note that all these 
cases made an uneventful recovery. 
Where the total dosage was 27 to 30 tablets - 
132 to 15 grms. - only one case failed to respond and 
here again there was severe vomiting. Once again 
these cases made a good recovery. 
When the final dose was not more than 36 tablets 
- 18 grms. - the immediate response was for the most 
part good. In five cases, however, the convalescence 
was interrupted by further rises in temperature which 
were not completely influenced by the drug. 
In those cases in which a total of from 15 to 25 
grms. of M. & B. 693 was given, two failed to respond 
and had continued temperature uninfluenced by the drug. 
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Another responded but the temperature rose forty -eight 
hours later and again fell with ,ï. . B. 693. 
A dosage in excess of 25 grms. - 50 tablets - was 
givens in nineteen cases. In ten of these the only 
reason for so doing was to assess the end effects. In 
so far as the i_7mediate response and subsequent con- 
valescence were concerned, there was nothing to note. 
In the remaining nine the drug was continued because 
of complications which are shown in the Tables 15 (a) 
and (b) . 
My experience with `:'. B. 693 leads me to believe 
that the drug exerts its influence _vainly on the early 
stages of the disease, and for this reason I believe 
that a dosage of 7 -8 grms. - 14 -16 tablets - should 
be given in the first twenty -four hours after seeing 
patients. From the foregoing Tables it can be seen 
that the larger subsequent doses do not appear to 
prevent the onset of complicating factors, and further- 
more, once these factors have arisen it seems doubtful 
if i:. & B. 693 is capable of influencing them. Cases 
with uninterrupted convalescence occurred in the :Troup 
on the smallest total dosage and on the largest. 
Where complications occurred, larger doses were given 
but seemingly with little benefit. In view of this, 
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I do not consider that large subsequent doses are 
necessary. A total dosage of 14 -18 firms. - 28 -36 
tablets - should be sufficient in most cases. 
There is just one -,oint about those comlicating 
factors, such as a relighting of the pneumonic process. 
It seems that this illness is not so acute as it might 
otherwise have been. 
The actual effect of ;r;. J P. 693 on the pneumonic 
process in the lung is difficult to assess. On this 
point I agree with Pepper, Flippin and Schwartz54 
that once red hepatization has occurred, E. 693 
does not influence the process. It would appear that 
the changes in the lung progress as previously. 
In the normal course of events the lungs should have 
returned to normal within fourteen days (Price17), 
and this is the case in a great number of the present 
series. A certain proportion, however, showed delay 
in this process - E 10, E 11, H 15, D 5, D 3, M 2, C 7, 
C 9, G 2, G 7 - i.e. 11.63. 
Seven of these cases were X -rayed during convales- 




Case. X-ray Reports. 
Day after 
admission. 
W 2 Almost complete resolution 43 days 
C 7 Resolving Pneumonia 24 days 
E 11 Unresolved 37 days 
H 15 Still some obscurity 49 days 
C 9 Delayed resolution of 45 days 
Inflammatory Process 
G 2 Unresolved 15 days 
G 7 Consolidation ri`.ht base 15 days 
Considerable delay in resolution has thus appear- 
ed in some cases. It is of interest to note the 
dosage of Y. c: B. 693 that those patients received. 
This is shown in Table 17 below. 
It does not appear that the dosage of the drug 
bears any relationship to the prevention of delay in 
resolution, as this has occurred with as small a dose 
as 8 grms. - 16 tablets - and as large a dose as 33 
grms. - 66 tablets. 
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Table 17. 
Case No. Dose of _;'. B. 693 
Ni 2 17 grms. or 34 tabs. 
C 7 18 r If 36 n 
E 11 18 If r 36 r 
H 15 34 rr It 68 n 
C 9 8 r ff 16 ri 
G 2 22 n r 44 n 
G 7 322 If If 65 It 
E 10 26 If n 52 rr 
D 5 17 It r 34 t? 
D 3 162 ri rr 33 If 
A non -purulent pleural effusion occurred in two 
cases - G 9 and G 2 - causing an irregular rise in 
temperature. Aspiration of the fluid brought about 
complete recovery. 
Empyaema was present in two cases - H 10 and B 19. 
Both were due to Type II pneumococcus. Case B 19 was 
discharged to a convalescent home twenty days after 
admission, the temperature, etc., being normal. 
Eighteen days later, however, he showed signs of an 
inter -lobar pneumonia which had to be treated surgical- 
ly. H 10 also required surgical drainage. Y. B. 
693 is known to be present in purulent pleural exudates 
in a concentration of 3 to 2/3that of the blood con- 
centration, and the possibility of treating empyaema 
by repeated aspiration and continuation of the drug 
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has been suggested. In view of the fact that despit 
large doses of ï;_ . & B. 693 (H 16 had 36 firms .) , com- 
plications such as empyaema still occur, I do not 
feel that such treatment would be justifies at this 
stage. 
The incidence of empyaema during the preceding 
five years, in the Royal Infirmary, Edinburgh, is 
shown in Table 18. 
Table 18. 











From these figures it is not possible to give ani 
definite opinion as to whether or not the incidence of 
empyaema in cases treated with Y. w B. 693 is less 
than previously. It seems justifiable to say, however, 
that it is not higher than the average figure of the 
last five years. In seventy cases Smith and N eedles516 
had only one case of empyaema. Similarly, in one 
hundred cases Fliopin et al27 had none. In contrast 
to those we have Evans and Gaisford's11 figure of six 
cases of empyaema in sixty cases treated with the drug. 
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The toxicity of M. p. B. 693 for man was judged to 
be low by Evans and Csisford11 in their ori,inal in- 
vestiration. My findings agree with theirs in that 
I found the main toxic symptoms to be cyanosis and 
vomiting. These proved to be more troublesome than 
dangerous. 
Cyanosis occurred in 8.1% of the patients in a 
varying degree, but in none was it considered neces- 
dart' to discontinue the drug, and at the end of treat- 
ment the methaemoglobinuria cleared. rapidly. 
Nausea and vomiting were encountered. in 15P of 
the cases. In only four - A 10, C 9, D 1, C 11 - was 
it found necessary to stop the administration of the 
drug. 
A 10 had severe vomiting_ after she had received 
twenty -eight tablets in two days. The drug was dis- 
continued and the temperature fell by lysis on the 
ninth day. 
D 1 had twenty -two tablets before vomiting and the 
temperature had fallen less than twelve hours after 
admission. The dru+T: was discontinued but the tempera- 
ture rose again on the sixth day, when the drug was 
recommenced in spite of a tendency to vomit. 
C 11 received in all twenty -three tablets before 
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the drug had to be stopped because of vomiting. The 
temperature fell after fourteen tablets, and remained 
normal. 
C 9 had sixteen tablets before vomiting made it 
necessary to discontinue the drug. Flippin et alt' 
had vomiting in 40:: of their one hundred cases. 
'Nhere vomiting was threatened, certain measures 
were instituted to attempt to overcome this, viz. the 
tablets were crusned and given in milk, or a mixture 
of sodium bicarbonate (30 grains) was given with the 
drug, with satisfying results. Flippin et al27 
believe that a mixture of sodium chloride and dextrose, 
given intravenously, is the best method of combating 
vomiting. 
Toxic symptoms of a much more severe character 
have been reported, but fortunately they are the ex- 
ception rather than the rule. Tn one hundred cases. 
Flippin et al27 had a case in which the white blood 
count was reduced. to 1800. Graham et al`E report a 
case of granulocytopenia after 79 grms. (158 tablets) 
M. x B. 693. with recovery, and Barnett et al34 report 
the death of a child aged ten after M.9 grms. (161 
tablets) M. & B. 693 in seventeen days. These two 
latter cases were both given very high dosages of the 
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drug. All cases in this series had white blood 
counts made on admission, most of them after an inter- 
val of from three to five days, and a considerable 
number towards the tenth day after admission. In none 
was there a fall of the white cell count to a level 
lower than that which would normally be found as the 
condition improved. Blood films were not made so no 
opinion can be given as to whether the drug was res- 
ponsible for any alteration in the characters of 
members of the white series. 
A point of some interest in treatment of pneu- 
monia with Y. & B. 693 was to endeavour to determine 
if there was any shortening of the duration of stay 
in hospital. This is a matter of no small importance 
when one considers the demand 
hospitals, and also the added 
that each day of stay therein 
cases the average duration of 
for beds in our general 
expense of maintenance 
means. In uncomplicated 
stay of each patient was 
18.6 days. This compares very favourably with the 
duration of stay in previous years. 
shown in Table 19 below. 
Table 19. 



























It is not yet possible to give an opinion on 
whether there is any shortening of the period of con- 
valescence or not. It is perhaps not too much to 
hope that when the patient is spared the strain and 
absorption of toxins of the early days of the disease 
that his period of recovery may be shortened. 
A matter of great importance is the cost of such 
a drug. Is it within the reach of all pockets or is 
it such that it can only be obtained by the richer 
members of society or in hospital? It has the advan- 
tage of being relatively cheap. For 50 tablets, or 
25 grins., which is the maximum dosage required in most 
cases, the cost is in the region of twelve shillings. 
Not only has i,.. a. B. 693 the advantage of being 
relatively cheap itself, but its use makes the employ- 
ment of other expensive material previously necessary 
in pneumonia, e.g. oxygen, seldom necessary or, if 
needed, then for a much shorter time. 
B. 693 has therefore shown itself to be a 
definite advance in the fight against pneumonia, being 
universally applicable, simple in use, relatively free 
from toxic symptoms which, as a rule, are not serious, 
and comparatively cheap. Also it acts in the rajority 
of cases of clinically diagnosed rneumonia and there 
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are no apparent contra- indications to its use. 
We have, then, a drug which can be used by the 
General Practitioner of Medicine in the treatment of 
pneumonia. Having made the clinical diagnosis of 
pneumonia there is no need for him to have the sputum 
typed. He can straightway employ the compound with- 
out fear of serious toxic symptoms, with the anxious 
seven days to the crisis removed, and with reasonable 
certainty of a favourable outcome for his patient. 
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S U M M A R Y. 
1. Eighty -five cases of pneumonia have been treated 
with 2- sulphanilyl amino pyridine .. L. 693. 
2. 74.1' the cases responded to treatment with 
M. 3z B. 693 in 24 -36 hours, e.g. - 
(a) A dramatic sharp fall in temperature, pulse 
and respiration rate to normal; 
(b) A striking improvement in the general well 
being of the patient. 
5.8` of the cases showed the same response in 
48 -72 hours. 
15.54 of the cases showed a variable response. 
3. L. B. 693 exerted an action on pneumonia caused 
by Types I, II, III and the members of Group IV 
pneumococcus. 
4. L. B. 693 exerted an action on pneumonia caused 
by the streptococcus. 
5. M. & B. 693 was indefinite and unreliable in its 
action on pneumonia due to mixed pneumococcal 
or other mixed infections. 
6. The action of r,. & B. 693 occurred irrespective 
of the day of the disease. 
7. M. & B. 693 was effective in pneumonia in all the 
age groups in this series. 
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8. Four cases in this series died - a mortality of 
4.7%. This death -rate is compared with that 
occurring for the past five years in the Royal 
Infirmary, Edinburgh. 
9. Favourable results from M. & B. 693 are dependent 
on an adequate dose when drug is first given. 
10. A dose of 7 -8 grms - 14 -16 tablets - should be 
given in the first 24 hours of administration. 
11. Providing a dose of 7 -8 grms is given in the firs 
24 i_ours of administration, subsequent dosage 
is not so important, the outcome being as good 
in cases on low total dosage as high. 
12. M. & B. 693 does not influence the pneumonic 
process in the lungs. 
13. 11.6% of cases in the series showed delayed 
resolution. 
14. Delay in resolution does not appear to be influer 
ed by total dosage of M. & B. 693, cures occur- 
ring with low and high total doses. 
15. Empyaema occurred in two cases. 
16. No severe toxic symptoms occurred. 
Vomiting was present in 15% of cases; in four 
cases the drug had to be stopped. 
Cyanosis was present in 8.1% of cases. 




17. Duration of stay in hospital in uncomplicated 
cases .eras 1).6 days. This is compared with 
the stay in previous years. 
1E. No conclusion is possible as to any change in the 
length of convalescent period. 
19. The cost of the drug is within the reach of most 
people. 
20. Y. & B. 693 is a definite advance in the therapy 
of pneumonia. 
21. Y. B. 693 can be used with safety and reasonable 
hope of certainty by the General Practitioner 
of ivíedicine . 
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